[
    {
        "id": 1,
        "Question": "Proteins interact with which part of the cell membrane?",
        "Options": [
            "a) Hydrophobic tail",
            "b) Polar head",
            "c) Non polar head",
            "d) Hydrophilic tail",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 2,
        "Question": "Which part of the membrane is responsible for the relative impermeability of polar molecules in and out of the cell?",
        "Options": [
            "a) Polar head",
            "b) Hydrophobic head",
            "c) Hydrophobic core",
            "d) Non polar head",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 3,
        "Question": "What helps in the passing of inorganic ions?",
        "Options": [
            "a) Ion channels",
            "b) Voltage gated channels",
            "c) Aqueous filled pores",
            "d) Diffusion",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 4,
        "Question": "The cell membrane is ___________",
        "Options": [
            "a) Impermeable",
            "b) Semipermeable",
            "c) Permeable",
            "d) Permeable to only gases",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 5,
        "Question": "What is the most important characteristic of a drug to be absorbed after oral administration?",
        "Options": [
            "a) Dissolved in HCL",
            "b) Dissolved in alkaline solution",
            "c) Can pass through the cell membrane",
            "d) Form aggregate and settle down",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 6,
        "Question": "Which one of these is an example of Enteral Route?",
        "Options": [
            "a) Skin",
            "b) IV",
            "c) Gastrointestinal",
            "d) Inhalation",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 7,
        "Question": "Gastrointestinal route is an example of which of the major drug delivery routes?",
        "Options": [
            "a) The enteral route",
            "b) The parenteral route",
            "c) The topical route",
            "d) The intravenous route",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 8,
        "Question": "Which is the major process of absorption for more than 90% of drugs?",
        "Options": [
            "a) Facilitated diffusion",
            "b) Active transport",
            "c) Endocytosis",
            "d) Passive diffusion",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 9,
        "Question": "What is the driving force for Passive Diffusion?",
        "Options": [
            "a) Concentration gradient only",
            "b) Electrochemical gradient only",
            "c) Charge equilibration and concentration gradient",
            "d) Concentration and Electrochemical gradient both",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 10,
        "Question": "Which kind of molecules cannot pass through a pore transport?",
        "Options": [
            "a) Low Molecular weight molecules",
            "b) Water-soluble drugs",
            "c) Molecules up to 400 Dalton",
            "d) Molecules greater than 400 Dalton",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 11,
        "Question": "What is the driving force of Pore Transport?",
        "Options": [
            "a) Hydrostatic pressure",
            "b) Concertation Gradient",
            "c) Electrochemical gradient",
            "d) Charge equilibration",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 12,
        "Question": "What will be the best definition for “carrier”?",
        "Options": [
            "a) Nonpolar drugs can be transported through carrier-mediated transport",
            "b) Carrier binds reversibly and no covalently with the molecules",
            "c) It discharges the molecules and gets destroyed itself",
            "d) The carrier is a protein",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 13,
        "Question": "What is the major difference between Facilitated diffusion and Passive diffusion?",
        "Options": [
            "a) Carrier-mediated transport",
            "b) Downhill transport",
            "c) Energy is used",
            "d) Inhibition by metabolic poisons",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 14,
        "Question": "What influences the permeation of drugs in an Ionic or Electrochemical diffusion?",
        "Options": [
            "a) Charge on the membrane",
            "b) Charge on the particle",
            "c) Concentration gradient",
            "d) Equilibration of charge",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 15,
        "Question": "Which kind of drugs are absorbed through endocytosis?",
        "Options": [
            "a) Molecular weight ranging 100-400Dalton",
            "b) Water-soluble drugs",
            "c) Macromolecular drugs or drugs as oily droplets",
            "d) Polar drugs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 16,
        "Question": "Which drugs are absorbed through pore transport?",
        "Options": [
            "a) High lipophilicity",
            "b) Water-soluble drugs of molecular weight less than 100 Dalton",
            "c) Oily droplets",
            "d) Affinity for carriers",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 17,
        "Question": "Which types of drugs get absorbed by ion-pair transport?",
        "Options": [
            "a) High lipophilicity",
            "b) Oily droplets",
            "c) Affinity for carriers",
            "d) Drugs that ionize at all pH conditions",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 18,
        "Question": "Which of these absorption methods involves engulfing of the extracellular drug?",
        "Options": [
            "a) Endocytosis",
            "b) Passive diffusion",
            "c) Facilitated diffusion",
            "d) Ion-Pair transport",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 19,
        "Question": "Which is the other name of “cell eating”?",
        "Options": [
            "a) Transcytosis",
            "b) Phagocytosis",
            "c) Pinocytosis",
            "d) Endocytosis",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 20,
        "Question": "Transfer of an endocytic vesicle from one extracellular compartment to another is known as _____________",
        "Options": [
            "a) Phagocytosis",
            "b) Transcytosis",
            "c) Pinocytosis",
            "d) Endocytosis",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 21,
        "Question": "Which one of these is a physicochemical property of Drug substance?",
        "Options": [
            "a) Drug solubility",
            "b) Disintegration time",
            "c) Age of patient",
            "d) Dissolution time",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 22,
        "Question": "Which one of these does not come under a physicochemical property of drugs?",
        "Options": [
            "a) Drug solubility",
            "b) Disintegration time",
            "c) Dissolution rate",
            "d) Drug stability",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 23,
        "Question": "In the sequence of events in the drug absorption from orally administered solid dosage, which one comes at first?",
        "Options": [
            "a) Disintegration",
            "b) Disaggregation",
            "c) Dissolution",
            "d) Absorption",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 24,
        "Question": "Which one is the correct sequence for drug absorption through the oral route?",
        "Options": [
            "a) Absorption – Dissolution – Disintegration – Deaggregation",
            "b) Disintegration – Dissolution – Deaggregation – Absorption",
            "c) Disintegration – Deaggregation – Dissolution – Absorption",
            "d) Disintegration – Deaggregation – Absorption – Dissolution",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 25,
        "Question": "Patient-related factors of drug absorption do not deal with which one of these?",
        "Options": [
            "a) Age",
            "b) Gastric Emptying time",
            "c) Intestinal transit time",
            "d) Pharmaceutic ingredients",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 26,
        "Question": " The rate at which drug reaches the systemic circulation is determined by the slowest of the various steps involved in the sequence. This is known as ____________",
        "Options": [
            "a) Disintegration time",
            "b) Dissolution time",
            "c) Rate limiting step",
            "d) Gastric Emptying time",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 27,
        "Question": "Which one of the following is a critical rate-limiting step of drug absorption?",
        "Options": [
            "a) Rate of drug disintegration",
            "b) Size of the drug",
            "c) Size of the porous particle",
            "d) Rate of dissolution",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 28,
        "Question": "Which sentence will define the Dissolution rate?",
        "Options": [
            "a) Amount of solid substrate that goes into solution under constant time",
            "b) Amount of solid substrate that goes into solution under constant time under standard temperature",
            "c) Amount of solid substrate that goes into solution under constant time under standard temperature, pH, and pressure",
            "d) Amount of solid substrate that goes into solution under constant time under standard temperature, pH, solvent composition and constant surface area",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 29,
        "Question": "What should be the ideal solubility rate of an orally administered drug in the pH range of 2 to 8?",
        "Options": [
            "a) 3-4mg/ml",
            "b) 4-6 mg/ml",
            "c) 7-8 mg/ml",
            "d) 1-2 mg/ml",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 30,
        "Question": "Which one of these is not a theory of Drug dissolution?",
        "Options": [
            "a) Diffusion layer model",
            "b) Fick’s law of diffusion",
            "c) Penetration or surface renewal theory",
            "d) Interfacial barrier model",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 31,
        "Question": "Which theory takes into account that a thin film is created by the solution of the solid at the solid-liquid interface?",
        "Options": [
            "a) Interfacial barrier model",
            "b) Diffusion layer model",
            "c) Penetration or surface renewal theory",
            "d) Danckwert’s model",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 32,
        "Question": "In the equation G=Ki (Cs-Cb), what does G stands for______________",
        "Options": [
            "a) Dissolution rate per unit area",
            "b) Effective interfacial transport constant",
            "c) Concentration of the solute",
            "d) Concentration of the impurity",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 33,
        "Question": "Which model does not approve the existence of the stagnant layer in the solid-liquid interface?",
        "Options": [
            "a) Interfacial barrier model",
            "b) Diffusion layer model",
            "c) Penetration or surface renewal theory",
            "d) Danckwert’s model",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 34,
        "Question": "What does the interfacial barrier model states?",
        "Options": [
            "a) An intermediate concentration exists at the interface",
            "b) Turbulence in the dissolution medium exists at the solid/liquid interface",
            "c) Formation a thin film or layer at the solid-liquid interface",
            "d) Solutes passes easily through the interfaces",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 35,
        "Question": "In the equation, Wo1/3-W1/3=Kt, K stands for ____________",
        "Options": [
            "a) The original mass of the drug",
            "b) Mass of the drug remaining after time t",
            "c) Dissolution constant",
            "d) Concentration of solute",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 36,
        "Question": "Which are the two rate-determining step of drug absorption when given orally?",
        "Options": [
            "a) Disintegration and deaggregation",
            "b) Disintegration and Dissolution",
            "c) Dissolution and permeation through the membrane",
            "d) Permeation through the membrane and Disintegration",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 37,
        "Question": "The maximum amount of solute dissolved in a given solvent under standard conditions of temperature, pressure, and pH is known as __________",
        "Options": [
            "a) Dissolution rate",
            "b) Intrinsic dissolution",
            "c) Rate limiting step",
            "d) Absolute or intrinsic solubility",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 38,
        "Question": "In the equation, V dC/dt = dm/dt = A(Cs-Cb).√ γ D, what does γ stands for?",
        "Options": [
            "a) Mass of the solid dissolved",
            "b) Rate of surface renewal",
            "c) Concentration of solute",
            "d) Concentration of the drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 39,
        "Question": "Which option will be the best example of the physicochemical properties of drugs?",
        "Options": [
            "a) Solubility, particle size, polymorphism, salt form, pseudopolymorphism, complexation, wettability, pH, Pressure of disintegration",
            "b) Pressure of disintegration, polymorphism, salt form, pseudopolymorphism, complexation, wettability, pH",
            "c) Solubility, particle size, polymorphism, salt form",
            "d) Solubility, particle size, polymorphism, salt form, pseudopolymorphism, complexation, wettability",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 40,
        "Question": "For oral formulation, what should be the minimum aqueous solubility to avoid bioavailability problems?",
        "Options": [
            "a) 0.9%",
            "b) 1%",
            "c) 2%",
            "d) 0.11%",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 41,
        "Question": "The total solid surface area of any particle is known as ___________",
        "Options": [
            "a) Absolute surface area",
            "b) Effective surface area",
            "c) Total surface area",
            "d) Surface area",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 42,
        "Question": "In the case of hydrophobic drugs, micronization results in a decrease in effective surface area and thus fall is dissolution rate. Which of the below sentences cannot be a reason for the given statement?",
        "Options": [
            "a) The hydrophobic surface of the drugs adsorbs onto their surface which inhibits their wettability",
            "b) The particles reaggregate to form larger particles due to their high surface free energy",
            "c) Extreme reduction in the particle size imparts surface charges that may prevent wetting",
            "d) Extreme reduction in the size brings the hydrophobic amino acids to the surface",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 43,
        "Question": "How the absolute surface area of hydrophobic drugs can be converted to their effective surface area?",
        "Options": [
            "a) Use of surfactant",
            "b) Use of Hydrophobic diluents",
            "c) Use of surfactant and hydrophilic diluents",
            "d) No need of doing micronization",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 44,
        "Question": "Which one of these is not an example of hydrophilic diluents?",
        "Options": [
            "a) PVC",
            "b) Dextrose",
            "c) PVP",
            "d) PEG",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 45,
        "Question": "The solvate can exist in different crystalline forms called as _________",
        "Options": [
            "a) Solvates",
            "b) Pseudopolymorphs",
            "c) Pseudopolymorphism",
            "d) Hydrate",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 46,
        "Question": "Which form of a drug has greater solubility?",
        "Options": [
            "a) Anhydrous",
            "b) Hydrate",
            "c) Crystallised",
            "d) Monohydrate",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 47,
        "Question": "Which one will be the easiest approach to enhance the solubility and dissolution of any drug?",
        "Options": [
            "a) Micronize the drug",
            "b) Convert drug into their anhydrous form",
            "c) Convert drug into their hydrous form",
            "d) Convert drug into their salt form",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 48,
        "Question": "What is pH?",
        "Options": [
            "a) –ve log of H+ concentration",
            "b) +ve log of H+ concentration",
            "c) Log of H+ concentration",
            "d) H+ concentration",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 49,
        "Question": "Which one of these is not an advantage of buffered aspirin tablets?",
        "Options": [
            "a) Enhanced bioavailability",
            "b) Reduced gastric irritation",
            "c) Increased stability",
            "d) Increased ulcerogenic tendency",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 50,
        "Question": "According to the pH-partition hypothesis which one of the given options doesn’t govern the absorption?",
        "Options": [
            "a) The molecular size of the drug",
            "b) PH at the absorption site",
            "c) Lipid solubility of unionized drugs",
            "d) Dissociation constant",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 51,
        "Question": "Which of the following equations correct for Henderson-Hasselbach equation for weak acids?",
        "Options": [
            "a) PH = pKa – log (Unionized drug concentration /Ionized drug concentration)",
            "b) PH = pKa – log (Ionized drug concentration/ Unionized drug concentration)",
            "c) PH = pKa + log (Ionized drug concentration/ Unionized drug concentration)",
            "d) PH = pKa + log (Unionized drug concentration /Ionized drug concentration)",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 52,
        "Question": "Which of the following equations correct for Henderson-Hasselbach equation for weak bases?",
        "Options": [
            "a) PH = pKa – log (Unionized drug concentration /Ionized drug concentration)",
            "b) PH = pKa – log (Ionized drug concentration/ Unionized drug concentration)",
            "c) PH = pKa + log (Ionized drug concentration/ Unionized drug concentration)",
            "d) PH = pKa + log (Unionized drug concentration /Ionized drug concentration)",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 53,
        "Question": "What is the pH range of the stomach?",
        "Options": [
            "a) 1-4",
            "b) 5-8",
            "c) 1-3",
            "d) 1-8",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 54,
        "Question": "What is the pH range of the intestine?",
        "Options": [
            "a) 4-5",
            "b) 1-3",
            "c) 1-8",
            "d) 5-8",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 55,
        "Question": "Which one of these is an example of a strong acid drug?",
        "Options": [
            "a) Diazepam",
            "b) Ibuprofen",
            "c) Cromolyn",
            "d) Aspirin",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 56,
        "Question": "Which one of these is not an example of a basic drug with pKa range 5-11?",
        "Options": [
            "a) Cromolyn",
            "b) Imipramine",
            "c) Amitriptyline",
            "d) Chloroquine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 57,
        "Question": "Example of a drug which has PKa > 11 is ________",
        "Options": [
            "a) Cromolyn",
            "b) Imipramine",
            "c) Amitriptyline",
            "d) Mecamylamine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 58,
        "Question": "What should be the range of oil/water partition coefficient of any drug?",
        "Options": [
            "a) 1-2",
            "b) 3-4",
            "c) 2-3",
            "d) 1-3",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 59,
        "Question": "Ibuprofen a weak acid, in the stomach will be present in which of the given form?",
        "Options": [
            "a) Ionized form mostly",
            "b) Non-ionized form mostly",
            "c) Half ionized and half no ionized",
            "d) Will form aggregate",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 60,
        "Question": "Nitrazepam a weak base, will be in which form in the stomach?",
        "Options": [
            "a) Ionized form mostly",
            "b) Non-ionized form mostly",
            "c) Half ionized and half no ionized",
            "d) Will form aggregate",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 61,
        "Question": "Heroin with pKa 7.8 will be in which form in intestinal pH?",
        "Options": [
            "a) Ionized form mostly",
            "b) Unionized form mostly",
            "c) Half ionized and half no ionized",
            "d) Will form aggregate",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 62,
        "Question": "Which one of these options is not one of the limitations of pH-partition theory?",
        "Options": [
            "a) Presence if virtual membrane pH",
            "b) Absorption of ionized drugs",
            "c) Influence of GI surface area",
            "d) Dissolution rate",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 63,
        "Question": "According to the pH-partition theory which form of the drug gets absorbed mostly?",
        "Options": [
            "a) Hydrated form",
            "b) Aggregated form",
            "c) Ionised",
            "d) Unionised",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 64,
        "Question": "What helps the ionized drug molecules to pass through the cell membrane passively?",
        "Options": [
            "a) Different pH",
            "b) Polar group",
            "c) Large lipophilic group",
            "d) Hydration",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 65,
        "Question": "What could be the reason that irrespective of pH any drug gets absorbed mostly from the intestine?",
        "Options": [
            "a) More surface area",
            "b) Long residence time",
            "c) Large surface area and long residence time",
            "d) Large surface area, long residence time, basic pH",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 66,
        "Question": "What are the major stability problems which result in poor bioavailability of any orally administered drugs?",
        "Options": [
            "a) Acidic degradation",
            "b) Degradation by salivary amylase",
            "c) Degradation of the drug in inactive form",
            "d) Interaction with the excipients and degradation in an inactive form",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 67,
        "Question": "Which form of drug formulation has disintegration time?",
        "Options": [
            "a) Injections",
            "b) Syrups",
            "c) Capsules and Tablets",
            "d) Only tablets",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 68,
        "Question": "Which tablets have longer Disintegration time?",
        "Options": [
            "a) Single coated tablets",
            "b) Uncoated tablets",
            "c) Sugar-coated tablets",
            "d) Capsules",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 69,
        "Question": "Which of the following is not a form of excipients?",
        "Options": [
            "a) Paracetamol",
            "b) Disintegrants",
            "c) Lubricants",
            "d) Binders",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 70,
        "Question": "Which of the following is not a limitation granulation?",
        "Options": [
            "a) Formation of crystal bridge by the presence of liquid",
            "b) The liquid may act as a medium for affecting chemical reactions such as hydrolysis",
            "c) Increase the cost due to more additional processing",
            "d) The drying step may harm the thermolabile drugs",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 71,
        "Question": "Which of these is not a characteristic of tablet formulation by Agglomerative phase of the communication process?",
        "Options": [
            "a) Tablets are stronger",
            "b) Usage of more binding agent",
            "c) Rapid dissolution",
            "d) Increase in internal surface area of the granules",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 72,
        "Question": "Which one of them is not a common form of excipients of drug manufacturing?",
        "Options": [
            "a) Diluents",
            "b) Binders",
            "c) Sweeteners",
            "d) Essential oils",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 73,
        "Question": "Vehicles are the solvent system for the liquefied drug. Which one of them is not an example of a kind of vehicle?",
        "Options": [
            "a) Aqueous vehicle",
            "b) Non-aqueous water-miscible vehicles",
            "c) Non-aqueous water immiscible vehicles",
            "d) A salt solution of the drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 74,
        "Question": "Which one of the following will be an example of organic diluents?",
        "Options": [
            "a) Starch",
            "b) Dicalcium phosphate",
            "c) Tetracycline",
            "d) Tween 80",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 75,
        "Question": "What is the function of a granulating agent in drug formulation?",
        "Options": [
            "a) Promote cohesive compacts",
            "b) Added if the required dosage is inadequate so that necessary bulk can be produced",
            "c) Tablets can disintegrate easily",
            "d) Used as solubilizer",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 76,
        "Question": "What is the full form of PVP and what is its function in drug formation?",
        "Options": [
            "a) Polyvinyl propylene, diluent",
            "b) Polyvinyl pyrrolidine, solubilizing agent",
            "c) Polyvinyl propylene, buffering agent",
            "d) Polyvinyl pyrrolidine, Binding agent",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 77,
        "Question": "Which one of the following sentences depicts the function of Disintegrants correctly?",
        "Options": [
            "a) These agents help in holding the powders together to form granules",
            "b) These agents overcome the cohesive strength of the tablets and help in dissolution",
            "c) These agents help in the flow of granules and reduce friction between particles",
            "d) Added when the required dosage is inadequate",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 78,
        "Question": "An example of lubricants will be __________",
        "Options": [
            "a) PVP",
            "b) Carbowaxes",
            "c) CMC",
            "d) Tetracycline",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 79,
        "Question": "The deleterious effect of various coatings on drug dissolution is shown in orders below. Which one of them is the correct order?",
        "Options": [
            "a) Enteric coat > sugar coat > nonenteric film coat",
            "b) Enteric coat > nonenteric film coat > sugar coat",
            "c) Nonenteric film coat > sugar coat > enteric coat",
            "d) Sugar coat > enteric coat > nonenteric film coat",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 80,
        "Question": "Which of the following will be an example of an organic suspending agent?",
        "Options": [
            "a) CMC",
            "b) MC",
            "c) Acacia",
            "d) Carbowaxes",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 81,
        "Question": "Which one of these is not a mechanism of the working of surfactants?",
        "Options": [
            "a) Promote wetting by increasing the effective surface area",
            "b) Helps in the dissolution of drug",
            "c) Better membrane contact of the drug",
            "d) Decrease membrane permeability",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 82,
        "Question": "PABA complex is used for the enhancement of ______________",
        "Options": [
            "a) Enhanced chelation",
            "b) Enhanced dissolution",
            "c) Enhanced membrane permeability",
            "d) Enhanced lipophilicity",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 83,
        "Question": "Which of the following will be the slowest step in tablet drug absorption?",
        "Options": [
            "a) Tablet disintegration to granules",
            "b) Granules disintegration to fine particles",
            "c) Fine particles dissolution",
            "d) Dissolution absorbed into the blood",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 84,
        "Question": "Which form of the drug has the highest bioavailability?",
        "Options": [
            "a) Coated tablets",
            "b) Solutions",
            "c) Tablets",
            "d) Emulsions",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 85,
        "Question": "Why emulsion dosage form for lipophilic drugs proved better?",
        "Options": [
            "a) Easy manufacturing",
            "b) The higher stability of the drug in emulsion form",
            "c) Presented a large surface area of oil to the GIT for the absorption of the drug",
            "d) Fast clearance from the plasma",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 86,
        "Question": "Which is the major rate-limiting step in the absorption of a drug from suspension dosage?",
        "Options": [
            "a) Tablet disintegration to granules",
            "b) Granules disintegration to fine particles",
            "c) Fine particles dissolution",
            "d) Dissolution absorbed into the blood",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 87,
        "Question": "Which coating is thin and dissolve rapidly?",
        "Options": [
            "a) Sugar coating",
            "b) Film coating",
            "c) Enteric coating",
            "d) Sealing coating",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 88,
        "Question": "Which option describes the function of the enteric coated drug?",
        "Options": [
            "a) Tough dissolves slowly",
            "b) Thin dissolves completely",
            "c) Dissolves only in alkaline pH of the intestine",
            "d) Shellac coating",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 89,
        "Question": "From the below options which will be the most widely used form of dosage?",
        "Options": [
            "a) Emulsion",
            "b) Solutions",
            "c) Tablets",
            "d) Powders",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 90,
        "Question": "What is the mean length of GIT?",
        "Options": [
            "a) 350 cm",
            "b) 200cm",
            "c) 400cm",
            "d) 450cm",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 91,
        "Question": "The entire length of the GI is lined by ___________",
        "Options": [
            "a) Blood vessels",
            "b) Nerves",
            "c) Mucopolysaccharides",
            "d) No lining direct contact with the cell",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 92,
        "Question": "Which drugs get absorbed in the stomach mostly?",
        "Options": [
            "a) Basic drugs",
            "b) Acidic Drugs",
            "c) Neutral drugs",
            "d) No drug gets absorbed in the stomach",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 93,
        "Question": "Which drugs gets mostly absorbed from the mouth?",
        "Options": [
            "a) Acidic drugs and lipophilic drugs",
            "b) Lipophilic drugs and neutral drugs",
            "c) Neutral drugs and lipophilic drugs",
            "d) Lipophilic, neutral, basic drugs",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 94,
        "Question": "From the surface of villi protrude smaller projection known as __________",
        "Options": [
            "a) Microvilli",
            "b) Villus",
            "c) Fingers",
            "d) Cilia",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 95,
        "Question": "Which of the following sentences will be the actual definition of folds of Kerckring?",
        "Options": [
            "a) Folds of the intestinal mucosa",
            "b) Finger-like projections whose other name is villi",
            "c) Protruding surface from the villi",
            "d) Cilia over the surface of villi",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 96,
        "Question": "Which one of the following is not a characteristic for the small intestine?",
        "Options": [
            "a) Peristaltic movement",
            "b) Long transit time",
            "c) High permeability",
            "d) PH 4-9",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 97,
        "Question": "How can we increase the time of gastric emptying?",
        "Options": [
            "a) By drinking a lot of water",
            "b) By taking a drug in empty stomach",
            "c) By taking the drug after food",
            "d) Cannot increase the time of gastric emptying at all",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 98,
        "Question": "What is the gastric emptying rate?",
        "Options": [
            "a) The time required for the gastric contents to empty into the small intestine",
            "b) Time is taken for half of the contents in the stomach to empty",
            "c) The speed at which the stomach contents empty into the intestine",
            "d) There is no such term",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 99,
        "Question": "How can we study the gastric emptying of a given drug?",
        "Options": [
            "a) By mixing the colour with the drug",
            "b) Waiting for the subject man to throw-up",
            "c) Tagging the drug with a radioisotope and scanning the stomach",
            "d) Waiting for the patient to pass feces",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 100,
        "Question": "Up to how much the microvilli in the small intestine increases the relative surface area of the small intestine?",
        "Options": [
            "a) 3 times",
            "b) 30 times",
            "c) 100 times",
            "d) 600 times",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 101,
        "Question": "What is the main role of the large intestine?",
        "Options": [
            "a) Absorption of water and electrolytes",
            "b) Absorption of minerals",
            "c) Absorption of glucose",
            "d) Absorption of only water",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 102,
        "Question": "Which one is the sublingual route?",
        "Options": [
            "a) Drug placed between cheek and gum",
            "b) Drug place between the tongue and upper palate",
            "c) Drug placed under the tongue",
            "d) Drug crushed and placed under the tongue",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 103,
        "Question": "Which one of the following is the buccal route?",
        "Options": [
            "a) Drug placed between cheek and gum",
            "b) Drug place between the tongue and upper palate",
            "c) Drug placed under the tongue",
            "d) Drug crushed and placed under the tongue",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 104,
        "Question": "Which one of the following is not an advantage of sublingual or buccal administration?",
        "Options": [
            "a) Rapid absorption and higher blood levels",
            "b) No first-pass hepatic metabolism",
            "c) No degradation of drugs",
            "d) Limited surface area",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 105,
        "Question": "Which is the largest organ of the human body?",
        "Options": [
            "a) Liver",
            "b) Stomach",
            "c) Skin",
            "d) Lungs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 106,
        "Question": "What is the principal barrier for the drugs on the topical application?",
        "Options": [
            "a) The Dermis",
            "b) The subcutaneous fat tissue",
            "c) The stratum corneum",
            "d) The blood vessels below the skin",
            ""
        ],
        "Answer": "Answer:  c"
    },
    {
        "id": 107,
        "Question": "Which of the following decreasing order of blood flow rate through the muscular tissue is in the right order?",
        "Options": [
            "a) Arm > thigh > buttocks",
            "b) Arm > buttocks > thigh",
            "c) Buttocks > thigh > arm",
            "d) Thigh > arm > buttocks",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 108,
        "Question": "Which of the following drug is not intended for pulmonary administration?",
        "Options": [
            "a) Bronchodilators",
            "b) Antiallergics",
            "c) NSAIDs",
            "d) Anti-inflammatory steroids",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 109,
        "Question": "Which one of the following sentences will be the actual definition of distribution?",
        "Options": [
            "a) Transfer of drug from the administration dosage to surrounding fluid",
            "b) Transfer of drug from the surrounding the fluid to the blood",
            "c) Transfer of the drug from the oral cavity to the intestine",
            "d) Reversible transfer of drug between blood and extravascular fluids and tissues",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 110,
        "Question": "What should be the molecular weight of the drug molecules so that they can easily pass through the membrane?",
        "Options": [
            "a) 600-800 Dalton",
            "b) 500-600 Dalton",
            "c) 300-500 Dalton",
            "d) 200-400 Dalton",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 111,
        "Question": "Which type of drug cannot enter the cell membrane in the below picture?",
        "Options": [
            "a) Ionized drug",
            "b) Unionized drug",
            "c) Hydrolyzed drug",
            "d) Unhydrated drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 112,
        "Question": "Which drugs cannot pass the Capillary endothelial Barrier?",
        "Options": [
            "a) Molecular size less than 600 Dalton",
            "b) Drugs bound to blood components",
            "c) Drugs bound to a chemical moiety",
            "d) All drugs can pass",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 113,
        "Question": "Which of the following drug cannot pass through the plasma membrane barrier?",
        "Options": [
            "a) Drug size less than 50 Dalton",
            "b) Lipophilic drugs 50-600 Dalton",
            "c) Polar or ionized drugs of size greater than 50 Dalton",
            "d) Drug size more than 600 Dalton",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 114,
        "Question": "Which cell make up the blood-brain barrier?",
        "Options": [
            "a) Squamous epithelium cells",
            "b) Fat cells",
            "c) Red blood cell",
            "d) Endothelial cells",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 115,
        "Question": "What is the name of the specialized cells that support the blood-brain barrier tissue?",
        "Options": [
            "a) Astrocytes",
            "b) Dendrites",
            "c) Fat cells",
            "d) Endothelial cells",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 116,
        "Question": "Why dopamine cannot be administered for the disease Parkinsonism?",
        "Options": [
            "a) Don’t have a medicine",
            "b) It is not the medicine",
            "c) Cannot cross the blood-brain barrier",
            "d) Forms aggregate and thus cannot cross the BBB",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 117,
        "Question": "Which one of these is not an approach to make the drug cross the blood-brain barrier?",
        "Options": [
            "a) Using permeation enhancers",
            "b) Osmotic disruption of the blood-brain barrier",
            "c) Use of highly lipophilic drug only",
            "d) Use of drug carriers to cross the BBB",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 118,
        "Question": "Which drugs can easily pass the Placental barrier?",
        "Options": [
            "a) Drugs having a molecular weight less than 1000 Dalton",
            "b) Moderate to high lipid solubility",
            "c) Drugs having a molecular weight less than 1000 Dalton and moderate to high lipid solubility, analgesics, and antibiotics",
            "d) Analgesics, antibiotics, etc",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 119,
        "Question": "What is the function of the blood-testis barrier?",
        "Options": [
            "a) Restricts the passage of drug to the testis",
            "b) Restricts the passage of drug to sperms",
            "c) Restricts the passage of drugs to spermatocytes",
            "d) Restricts the passage of drugs to spermatocytes and spermatids",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 120,
        "Question": "What is the perfusion rate?",
        "Options": [
            "a) The total volume of blood",
            "b) The volume of blood that flows through the heart per unit time",
            "c) The volume of blood that flows per unit time per unit volume of tissue",
            "d) The volume of tissue that flows per unit time per unit area of a blood vessel",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 121,
        "Question": "Who has more intracellular and extracellular water more in their body?",
        "Options": [
            "a) Aged",
            "b) Adults Of age more than 20",
            "c) Infants",
            "d) Children at puberty",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 122,
        "Question": "Who has higher fat content?",
        "Options": [
            "a) Adults of age above 70",
            "b) Adults of age more than 20",
            "c) Infants and elders",
            "d) Children at puberty",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 123,
        "Question": "Who has poorly developed BBB?",
        "Options": [
            "a) Infants",
            "b) Adults Of age more than 20",
            "c) Aged",
            "d) Children at puberty",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 124,
        "Question": "During pregnancy, drug distribution is more. Which of the following sentences describe the given fact better?",
        "Options": [
            "a) The baby needs more drug",
            "b) The mother needs more drug due to high metabolism",
            "c) The surface area increases in the mother’s body due to the presence of uterus, placenta, and foetus. Thus more area for distribution of drugs",
            "d) The growth of the uterus, placenta, and foetus increases the volume thus increasing distribution. And even the baby forms a separate compartment for a drug to get distributed",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 125,
        "Question": "What happens when an obese person is given with a lipophilic drug?",
        "Options": [
            "a) Drug aggregation will begin",
            "b) He cannot absorb lipophilic drugs",
            "c) High adipose tissue take up most of the lipophilic drug",
            "d) A large amount of drug is needed as the person’s weight is more",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 126,
        "Question": "What is the consequence of diet high in fats?",
        "Options": [
            "a) The patient can’t be given with acidic drugs",
            "b) The patient can’t be given with basic drugs",
            "c) The basic drugs will aggregate and become poisonous for him",
            "d) The high fatty acid level affect the binding of acidic drugs",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 127,
        "Question": "The extent to which a drug is distributed is a tissue depends upon ___________ and _____________",
        "Options": [
            "a) The concentration of a drug, tissue/blood partition coefficient of drug",
            "b) Tissue volume, tissue/blood partition coefficient of drug",
            "c) Tissue surface area, tissue/blood partition coefficient of drug",
            "d) Blood density upon the tissue, tissue/blood partition coefficient of drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 128,
        "Question": "Which one of the following has a high perfusion rate?",
        "Options": [
            "a) Fat",
            "b) Muscle and skin",
            "c) Lungs and kidney",
            "d) Bone",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 129,
        "Question": "Which one of the following has very low perfusion rate?",
        "Options": [
            "a) Fat and bone",
            "b) Muscle and skin",
            "c) Lungs and kidney",
            "d) Liver and Heart",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 130,
        "Question": "In equation X=Vd C, what does Vd denotes?",
        "Options": [
            "a) Density",
            "b) Volume of blood",
            "c) Volume of body",
            "d) The volume of the body fluid in which the drug is getting dissolved",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 131,
        "Question": "The body water has 3 distinct compartments. Which one of these is not one of the compartments?",
        "Options": [
            "a) Vascular fluid",
            "b) Intracellular fluid",
            "c) Extracellular fluid",
            "d) Between the tissue layers",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 132,
        "Question": "How can you determine the extracellular fluid volume?",
        "Options": [
            "a) Evans blue",
            "b) Na+",
            "c) D20",
            "d) Tritiated water",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 133,
        "Question": "How a patient’s plasma volume can be determined?",
        "Options": [
            "a) Evans blue",
            "b) Na+",
            "c) D20",
            "d) Tritiated water",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 134,
        "Question": "How will you determine the intracellular fluid volume?",
        "Options": [
            "a) Evans blue",
            "b) Na+",
            "c) Difference between total body water and ECF volume",
            "d) Tritiated water",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 135,
        "Question": "What will be the apparent volume of distribution of warfarin?",
        "Options": [
            "a) The apparent volume of distribution is less than the true volume of distribution",
            "b) The apparent volume of distribution is more than the true volume of distribution",
            "c) The apparent volume of distribution is equal to the true volume of distribution",
            "d) Warfarin is not a medicine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 136,
        "Question": "What will bet the apparent volume of distribution of drugs which binds selectively to extravascular tissues?",
        "Options": [
            "a) The apparent volume of distribution is less than the true volume of distribution",
            "b) The apparent volume of distribution is more than the true volume of distribution",
            "c) The apparent volume of distribution is equal to the true volume of distribution",
            "d) The apparent volume of distribution is equal to the volume of extravascular tissues",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 137,
        "Question": "Which one of the following bonds is not generally a bond through which a drug will bind in our body?",
        "Options": [
            "a) Hydrogen bond",
            "b) Hydrophobic bond",
            "c) Ionic bond",
            "d) Covalent bond",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 138,
        "Question": "Binding of drugs falls into 2 components those are _______________",
        "Options": [
            "a) Binding of drugs to blood components and to extravascular tissue",
            "b) Binding of drugs to blood components and to other cells",
            "c) Binding of drugs to cells and blood cells",
            "d) Binding of drugs to blood components to bones and cells",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 139,
        "Question": "Which one of the following is the correct order of the drugs binding to various plasma protein?",
        "Options": [
            "a) Albumin > alpha-1 acid glycoprotein > globulins  > lipoproteins",
            "b) Albumin > globulins  > lipoproteins > alpha-1 acid glycoprotein",
            "c) Albumin > alpha-1 acid glycoprotein > lipoproteins > globulins",
            "d) Albumin > lipoproteins  > globulins  > alpha-1 acid glycoprotein",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 140,
        "Question": "Which vitamin molecules will bind to alpha 2 globulin?",
        "Options": [
            "a) Vitamin b complexes",
            "b) Vitamin a and vitamin b",
            "c) Vitamin A, D, E, K",
            "d) Steroids bind to alpha 2 globulin, not vitamin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 141,
        "Question": "What is the molecular weight of human serum albumin?",
        "Options": [
            "a) 5000 Dalton",
            "b) 65,000 Dalton",
            "c) 60,000 Dalton",
            "d) 75,000 Dalton",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 142,
        "Question": "HSA comes under which protein family?",
        "Options": [
            "a) Globulin",
            "b) Receptor",
            "c) Enzymes",
            "d) Catalyst",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 143,
        "Question": "What is the name of the drug binding site I of HSA?",
        "Options": [
            "a) Tamoxifen binding site",
            "b) Digitoxin binding site",
            "c) Diazepam binding site",
            "d) Warfarin and azapropazone binding site",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 144,
        "Question": "Which one of the below does not belong to the 4 classes of lipoprotein?",
        "Options": [
            "a) Chylomicrons",
            "b) Very low-density lipoproteins",
            "c) High-density lipoprotein",
            "d) Fatty acids",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 145,
        "Question": "Which of the given drugs bind to Α1 globulin?",
        "Options": [
            "a) Steroidal drugs",
            "b) Vitamins A, D, E, K",
            "c) Ferrous ions",
            "d) Carotenoids",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 146,
        "Question": "What is the name of the drug binding site IV of HSA?",
        "Options": [
            "a) Tamoxifen binding site",
            "b) Digitoxin binding site",
            "c) Diazepam binding site",
            "d) Warfarin and azapropazone binding site",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 147,
        "Question": "Which of the given drugs bind to Β2 globulin?",
        "Options": [
            "a) Steroidal drugs",
            "b) Vitamins A, D, E, K",
            "c) Ferrous ions",
            "d) Carotenoids",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 148,
        "Question": "What is the name of the drug binding site III of HSA?",
        "Options": [
            "a) Tamoxifen binding site",
            "b) Digitoxin binding site",
            "c) Diazepam binding site",
            "d) Warfarin and azapropazone binding site",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 149,
        "Question": "Which drugs bind to RBC membrane?",
        "Options": [
            "a) Pentobarbital",
            "b) Acetazolamide",
            "c) Imipramine",
            "d) Phenytoin",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 150,
        "Question": "What is the name of the drug binding site II of HSA?",
        "Options": [
            "a) Tamoxifen binding site",
            "b) Digitoxin binding site",
            "c) Diazepam binding site",
            "d) Warfarin and azapropazone binding site",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 151,
        "Question": "What reasons make tissue-drug binding important for drug distribution?",
        "Options": [
            "a) Increases the volume of distribution of drugs and results in localization of drug at a specific site",
            "b) Increases the volume of distribution of drugs",
            "c) Results in localization of drugs at a tissue specific site",
            "d) Increases in absorption from the tissue due to concentration increasing",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 152,
        "Question": "Following is the order in decreasing order of drug binding to the extravascular tissue. Which one is the correct order?",
        "Options": [
            "a) Liver > kidney > muscle  > lung",
            "b) Liver > muscle  > lung > kidney",
            "c) Liver > muscle  > kidney  > lung",
            "d) Liver > kidney > lung > muscle",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 153,
        "Question": "What is the relation between halogenated hydrocarbon and liver?",
        "Options": [
            "a) Halogenated hydrocarbon is a drug for liver problems",
            "b) Halogenated hydrocarbon is nutrition for liver",
            "c) Halogenated hydrocarbon causes hepatotoxicity",
            "d) Halogenated hydrocarbon forms the bile juices in liver",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 154,
        "Question": "Which drugs accumulate in liver?",
        "Options": [
            "a) Acidic drugs like imipramine",
            "b) Basic drugs like imipramine",
            "c) Halogenated hydrocarbons",
            "d) Chloroquinine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 155,
        "Question": "Which metals get accumulated in the kidney?",
        "Options": [
            "a) Mercury, cadmium, lead",
            "b) Mercury, cadmium, iron",
            "c) Mercury, lanthanum, lead",
            "d) Mercury, cadmium, fluoride ions",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 156,
        "Question": "Which of the following drugs accumulate in skin?",
        "Options": [
            "a) Acidic drugs like imipramine",
            "b) Basic drugs like imipramine",
            "c) Halogenated hydrocarbons",
            "d) Chloroquine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 157,
        "Question": "Which of the following drugs are responsible for retinopathy?",
        "Options": [
            "a) Acidic drugs like imipramine",
            "b) Basic drugs like imipramine",
            "c) Halogenated hydrocarbons",
            "d) Chloroquinine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 158,
        "Question": "Which drugs deposit in hair shafts?",
        "Options": [
            "a) Arsenicals",
            "b) Tetracycline",
            "c) Halogenated hydrocarbons",
            "d) Lipophilic drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 159,
        "Question": "Which drug causes brown yellow discoloration of infant’s teeth?",
        "Options": [
            "a) Arsenicals",
            "b) Tetracycline",
            "c) Halogenated hydrocarbons",
            "d) Lipophilic drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 160,
        "Question": "Which drug accumulate in adipose tissue?",
        "Options": [
            "a) Arsenicals",
            "b) Tetracycline",
            "c) Halogenated hydrocarbons",
            "d) Lipophilic drug",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 161,
        "Question": "Which drugs results in distortion of double stranded DNA structure?",
        "Options": [
            "a) Arsenicals",
            "b) Quinacrine",
            "c) Halogenated hydrocarbons",
            "d) Lipophilic drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 162,
        "Question": "Which one of the following factors related to protein-drug binding is not related to drugs?",
        "Options": [
            "a) Physicochemical characteristics of a drug",
            "b) The concentration of the drug in the body",
            "c) The affinity of the drug for binding",
            "d) Number of binding sites on the binding agent",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 163,
        "Question": "Which one of the following factor related to protein-drug binding is not related to drug interactions with the binding site?",
        "Options": [
            "a) Competition between the drug and the binding site",
            "b) Competition between drugs and normal body constituents",
            "c) Allosteric changes in a protein molecule",
            "d) Inter subject variation",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 164,
        "Question": "Which of the following factors for protein drug binding is a drug interaction factor?",
        "Options": [
            "a) Competition between drugs for the binding site",
            "b) Age",
            "c) Physicochemical characteristics of a drug",
            "d) Physicochemical characteristics of the protein or binding agent",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 165,
        "Question": "Which drugs bind to HSA easily?",
        "Options": [
            "a) Cationic drug",
            "b) Anionic drug",
            "c) Lipophilic drug",
            "d) Neutral drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 166,
        "Question": "Which drugs easily bind to adipose tissue?",
        "Options": [
            "a) Cationic drug",
            "b) Anionic drug",
            "c) Lipophilic drug",
            "d) Neutral drug",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 167,
        "Question": "Which drug easily bind to AAG?",
        "Options": [
            "a) Cationic drug",
            "b) Anionic drug",
            "c) Lipophilic drug",
            "d) Neutral drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 168,
        "Question": "In the equation X= Vd C, what does X stands for?",
        "Options": [
            "a) Amount of drug in the blood",
            "b) Amount of drug in plasma",
            "c) Amount of drug in the tablet",
            "d) Amount of drug in the body",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 169,
        "Question": "Which of the following is a correct method to find the fraction of unbound drug in plasma? Given where Cu is the concentration of unbound drug and C is total plasma drug concentration.",
        "Options": [
            "a) CuC",
            "b) C / Cu",
            "c) Cu/C",
            "d) 1/C Cu",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 170,
        "Question": "What are xenobiotics?",
        "Options": [
            "a) Another form of antibiotics",
            "b) A form of nutrient",
            "c) Nutrients which kill the gut harmful microbes",
            "d) Anything that is not nutrients and enters the body through different routes",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 171,
        "Question": "What is the active form of salicylic acid?",
        "Options": [
            "a) Sialic acid",
            "b) Salic acid",
            "c) Salicylic acid",
            "d) Salicycle acid",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 172,
        "Question": "What is the inactive form of Codeine?",
        "Options": [
            "a) Codene",
            "b) Codane",
            "c) Morphine",
            "d) Poppy",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 173,
        "Question": "What are soft drugs?",
        "Options": [
            "a) Drugs given to babies",
            "b) Chemical drugs which are already found in the body",
            "c) Nutrients which kill the gut harmful microbes",
            "d) Anything that is not nutrients and enters the body through different routes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 174,
        "Question": "Which of the following is the correct decreasing order of drug metabolism?",
        "Options": [
            "a) Liver > lungs > kidneys > intestine > placenta > skin > adrenals",
            "b) Liver > lungs > kidneys > intestine > adrenals > placenta > skin",
            "c) Liver > kidneys > lungs > intestine > placenta > adrenals > skin",
            "d) Liver > lungs > intestine > kidneys > placenta > adrenals > skin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 175,
        "Question": "The enzymes are divided into two categories, these are _______ and ____________",
        "Options": [
            "a) Acidic drug metabolizing and basic drug metabolizing",
            "b) Present in the liver and not present in the liver",
            "c) Microsomal and non-microsomal",
            "d) There is no such division",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 176,
        "Question": "Microsome are selective to ____________",
        "Options": [
            "a) Water-soluble drugs",
            "b) Lipid soluble drugs",
            "c) Acidic drugs",
            "d) Basic drugs",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 177,
        "Question": "Where are non-microsomal enzymes present?",
        "Options": [
            "a) In the Golgi apparatus",
            "b) Inside lysosomes",
            "c) In the cytoplasm in soluble form",
            "d) In oxysomes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 178,
        "Question": "Following are the Phase I reactions except ____________",
        "Options": [
            "a) Oxidative reactions",
            "b) Hydrolytic reactions",
            "c) Reductive reactions",
            "d) Sulphide reactions",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 179,
        "Question": "What are the names of the 3 protein involve in multienzyme mixed-function oxidase system, located in the endoplasmic reticulum?",
        "Options": [
            "a) Heme protein, flavoprotein, phosphatidylcholine",
            "b) Heme protein, flavoprotein, retinal protein",
            "c) Heme protein, retinal protein, phosphatidylcholine",
            "d) Retinal protein, flavoprotein, phosphatidylcholine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 180,
        "Question": "What is the function of Phosphatidylcholine in multienzyme mixed-function oxidase system, located in the endoplasmic reticulum?",
        "Options": [
            "a) Oxidising the substrate",
            "b) Reducing the substrate",
            "c) Facilitate electron transfer from NADPH to cytochrome 450",
            "d) Facilitate electron transfer from cytochrome 450 to NADPH",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 181,
        "Question": "What is the function of a flavoprotein, located in the endoplasmic reticulum?",
        "Options": [
            "a) Oxidising the substrate",
            "b) Reducing the cytochrome-450 to the ferrous form",
            "c) Facilitate electron transfer from NADPH to cytochrome 450",
            "d) Facilitate electron transfer from cytochrome 450 to NADPH",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 182,
        "Question": "Which one is the rate-limiting step in the oxidation of xenobiotics?",
        "Options": [
            "a) Binding of the substrate to Fe3+",
            "b) Electron transfer from NADPH to the above complex",
            "c) The enzyme-substrate complex combines with a molecule of oxygen forming a ternary complex",
            "d) Ternary complex gains an electron from the NADPH",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 183,
        "Question": "What provides the atom of oxygen for the making of water?",
        "Options": [
            "a) From the cytochrome 450",
            "b) From the environment",
            "c) From the activated oxygen P-450 substrate complex",
            "d) From cytochrome reductase",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 184,
        "Question": "What is the major end product of oxidation of aromatic carbon atoms?",
        "Options": [
            "a) Arenols",
            "b) Catechol",
            "c) Glutathione",
            "d) Arene oxide",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 185,
        "Question": "Which one of the following is reactive and a known carcinogenic?",
        "Options": [
            "a) Cytochrome P-450",
            "b) Catechol",
            "c) Glutathione",
            "d) Arene oxide",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 186,
        "Question": "Which of the following is not a common N containing functional groups which undergo reduction reactions?",
        "Options": [
            "a) Nitro compounds",
            "b) Azo compounds",
            "c) N-oxide compounds",
            "d) Nitrite compounds",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 187,
        "Question": "Which enzymes catalyses the hydrolysis of amides?",
        "Options": [
            "a) Esterase",
            "b) Amydases",
            "c) Amidases",
            "d) Aminodases",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 188,
        "Question": "What is the end product of hydrolysis of Lidocaine?",
        "Options": [
            "a) 2, 6-Xylidine, N, N-Dimethylglycine",
            "b) 2, 5- Xylidine, Dimethylglycine",
            "c) Xylidine, glycine",
            "d) 1, 6-Xylidine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 189,
        "Question": "What is the end product of hydrolytic dehalogenation of DDT?",
        "Options": [
            "a) Dichloro diphenyl ethylene",
            "b) 1- chloro diphenyl dichloroethylene",
            "c) Trichloro triphenyl trichloroethylene",
            "d) Dichloro diphenyl dichloroethylene",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 190,
        "Question": "What does the hydrolysis of Aspirin yield us with?",
        "Options": [
            "a) Salicylic acid only",
            "b) Salicylic acid and CH3COOH",
            "c) CH3COOH",
            "d) Succinic acid",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 191,
        "Question": "Which enzyme is important in the Phase II reactions?",
        "Options": [
            "a) Esterase",
            "b) Amidases",
            "c) Transferase",
            "d) Aldo-keto-reductases",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 192,
        "Question": "Which of the following is not a characteristic of the moieties that are transferred to the substrate in phase II reactions?",
        "Options": [
            "a) Simple endogenous molecules are transferred",
            "b) Large molecular sized groups are attached",
            "c) Strong polar groups are attached",
            "d) Strong nonpolar groups are attached",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 193,
        "Question": "Which of the following statement is false?",
        "Options": [
            "a) D-glucuronic acid is easily available",
            "b) Several functional groups can be easily linked with the D-glucuronic acid",
            "c) Conjugation with D-glucuronic acid occurs to a high degree",
            "d) Whole animal kingdom have the common ability to produce D-glucuronic acid",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 194,
        "Question": "Which coenzyme is synthesized in the 1st step of the formation of Glucuronide?",
        "Options": [
            "a) Uridine triphosphate",
            "b) Uridine-5’-diphosphate-alpha-D-glucuronic acid",
            "c) UDP-glucose",
            "d) Glucuronide",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 195,
        "Question": "Which enzyme is of the utmost importance for the 2nd step in the formation of Glucuronide?",
        "Options": [
            "a) Esterase",
            "b) Amidases",
            "c) Transferase",
            "d) UDP-glucuronyl transferase",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 196,
        "Question": "Which one of the following is an example of Carboxyl compounds?",
        "Options": [
            "a) Meprobamate",
            "b) Sulfadimethoxine",
            "c) Sulphonamides",
            "d) Salicylic acids",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 197,
        "Question": "In the sulfation process, what is the name of the coenzyme formed in the 1st step?",
        "Options": [
            "a) 3’-phosphoadenosine-5’-phosphosulfate",
            "b) Adenosine triphosphate",
            "c) Adenosine-5’-phosphosulfate",
            "d) Uridine-5’-diphosphate-alpha-D-glucuronic acid",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 198,
        "Question": "Which enzyme’s presence is of utmost importance for the 2nd step of sulphation?",
        "Options": [
            "a) Sulfotransferase",
            "b) Amidases",
            "c) Transferase",
            "d) UDP-glucuronyl transferase",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 199,
        "Question": "Which of the following is not an example of a drug undergoing acetylation reaction?",
        "Options": [
            "a) Hydrazine",
            "b) Salicylic acids",
            "c) Sulphonamides",
            "d) Histamines",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 200,
        "Question": "What is enzyme induction?",
        "Options": [
            "a) The phenomenon of increased drug metabolizing ability of enzymes by drugs and chemicals",
            "b) The phenomenon of increasing drug bioavailability drugs and chemicals",
            "c) The phenomenon of increasing drug distribution drugs and chemicals",
            "d) The phenomenon of increasing drug concentration for a particular tissue by drugs and chemicals",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 201,
        "Question": "Which of the following drugs has self -induction to stimulate their own metabolism?",
        "Options": [
            "a) Cortisol",
            "b) Pentobarbital",
            "c) Meprobamate",
            "d) Contraceptives",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 202,
        "Question": "Alcohol is the inducer for which drug?",
        "Options": [
            "a) Cortisol",
            "b) Pentobarbital",
            "c) Meprobamate",
            "d) Oral contraceptives",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 203,
        "Question": "What is the name of the process where structurally same compounds compete for the same site on an enzyme to inhibit that?",
        "Options": [
            "a) Altered physiology",
            "b) Repression",
            "c) Non-competitive inhibition",
            "d) Competitive inhibition",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 204,
        "Question": "What is the name of the process where structurally different compounds interact with the enzyme and prevent the metabolism of the drug?",
        "Options": [
            "a) Altered physiology",
            "b) Repression",
            "c) Non-competitive inhibition",
            "d) Competitive inhibition",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 205,
        "Question": "What is the name of the process where the enzyme amount is decreased due to a decrease in enzyme synthesis?",
        "Options": [
            "a) Altered physiology",
            "b) Repression",
            "c) Non-competitive inhibition",
            "d) Competitive inhibition",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 206,
        "Question": "What is the name of the process where due to nutritional deficiency an enzyme content is decreased?",
        "Options": [
            "a) Altered physiology",
            "b) Repression",
            "c) Non-competitive inhibition",
            "d) Competitive inhibition",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 207,
        "Question": "Which one of the following is not an environmental agent to decrease drug metabolizing ability?",
        "Options": [
            "a) DDT",
            "b) Cigarette smoke",
            "c) Organophosphate insecticides",
            "d) Methacholine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 208,
        "Question": "What is polygenic control of drugs?",
        "Options": [
            "a) Drug controlling seen in an individual",
            "b) Drug controlling seen in twins",
            "c) Drug controlling seen in between different species",
            "d) Drug controlling seen in a particular population",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 209,
        "Question": "Differences observed in metabolism of drug among different races is known as ______________",
        "Options": [
            "a) Pharmacogenetics",
            "b) Ethnic variations",
            "c) Discontinues variation",
            "d) Polygenic control",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 210,
        "Question": "Which age group is known as the neonates?",
        "Options": [
            "a) Up to 2 months",
            "b) Up to 2 years",
            "c) Up to 6 months",
            "d) Up to 1 year",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 211,
        "Question": "Which age group metabolizes drugs faster than the adults?",
        "Options": [
            "a) Between 1-12 year",
            "b) Between 1-15 year",
            "c) Between 6-12 year",
            "d) Between 12-18 year",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 212,
        "Question": "Which of the following statement rightly states “bioactivation”?",
        "Options": [
            "a) Formation of high reactive metabolites which interact with tissues to precipitate toxic compounds",
            "b) Formation chelating agents",
            "c) Formation of enzymes which can lyse toxic compounds",
            "d) Stimulating the immune systems to initiate the formation of t cells",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 213,
        "Question": "Which of the following is an example of electrophiles?",
        "Options": [
            "a) Thalidomide",
            "b) Aflatoxin",
            "c) Epoxides",
            "d) Benzopyrene",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 214,
        "Question": "What is the body’s defence against electrophiles?",
        "Options": [
            "a) Their inactivation by conjugation with glucagon",
            "b) Their inactivation by conjugation with glutamine",
            "c) Their inactivation by conjugation with glucuronic acid",
            "d) Their inactivation by conjugation with glutathione",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 215,
        "Question": "Which xenobiotics yield free radicles on metabolic activation?",
        "Options": [
            "a) Thalidomide",
            "b) Aflatoxin",
            "c) Quinones",
            "d) Benzopyrene",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 216,
        "Question": "Which of the following will be an example of inorganic free radicle?",
        "Options": [
            "a) H2O2 and O2–",
            "b) Aflatoxin",
            "c) Quinones",
            "d) Benzopyrene",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 217,
        "Question": "How are electrophiles generated?",
        "Options": [
            "a) Through cytochrome P-450 system",
            "b) NADPH cytochrome P-450 reductase",
            "c) Different Flavin containing reductase",
            "d) Through cytochrome P-350 system",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 218,
        "Question": "How are free radicals generated in the human body?",
        "Options": [
            "a) Through cytochrome P-450 system",
            "b) NADPH cytochrome P-450 reductase",
            "c) NADPH reductase",
            "d) Through cytochrome P-350 system",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 219,
        "Question": "What is a prodrug?",
        "Options": [
            "a) An excipient which helps in creating the environment for the drug-dissolving",
            "b) Chemically drug precursor",
            "c) Excipient of drug formulation",
            "d) A drug which is used by professionals",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 220,
        "Question": "Which of the following is the correct characteristic of bio precursors/ metabolic precursors?",
        "Options": [
            "a) The inert carrier is attached through a chemical bond",
            "b) There is no inert carrier",
            "c) There is a change in pH while the formulation",
            "d) The active drug is converted to its inert form chemically",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 221,
        "Question": "“Cascade lantentiation” concept takes into account which kind of prodrugs?",
        "Options": [
            "a) Mixed type prodrugs",
            "b) Pro-prodrugs",
            "c) Bioprecursors",
            "d) Carrier linked prodrugs",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 222,
        "Question": "Prodrugs with two active compounds are known as ___________",
        "Options": [
            "a) Mixed type prodrugs",
            "b) Pro-prodrugs",
            "c) Bioprecursors",
            "d) Mutual prodrug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 223,
        "Question": "Which of the following is not a characteristic of ideal prodrug?",
        "Options": [
            "a) Should rapidly transform, chemically and enzymatically forming the active product",
            "b) Should have intrinsic pharmacological activity",
            "c) The vapour pressure should be less and evaporate easily",
            "d) Apart from an active product, other metabolic fragments should be nontoxic",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 224,
        "Question": "Which is the earliest discovered prodrug?",
        "Options": [
            "a) Prontosil",
            "b) Sulphanilamide",
            "c) Aspirin",
            "d) Salicylic acid",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 225,
        "Question": "Which of the following is an example of a mutual prodrug?",
        "Options": [
            "a) Prontosil is the prodrug for sulfanamide",
            "b) Aspirin is the prodrug of salicylic acid",
            "c) Benorylate prodrug for NSAIDs and paracetamol",
            "d) Diesters pro-prodrug for pilocarpic acid",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 226,
        "Question": "Which of the following will be a pharmaceutical application of prodrugs?",
        "Options": [
            "a) Enhancement of bioavailability",
            "b) Reduction of toxicity",
            "c) Improvement of odour",
            "d) Site-specific drug delivery",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 227,
        "Question": "Which of the following will be the pharmacokinetic application of prodrugs?",
        "Options": [
            "a) Improvement of taste",
            "b) Improvement of odour",
            "c) Site-specific drug delivery",
            "d) Reduction in GI irritation",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 228,
        "Question": "How improvement of a drug in case of taste is done?",
        "Options": [
            "a) Injecting the drug so no taste related problems",
            "b) Reducing the drug solubility in the saliva",
            "c) Lower affinity for the taste receptors and making the drug sweet",
            "d) Reducing drug solubility in saliva and lower affinity for taste receptors",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 229,
        "Question": "Which one of the following will be an example of changing the physical form of the drug to get a prodrug?",
        "Options": [
            "a) Ethyl mercaptan to 1,3-Diesters",
            "b) Trichloroethanol to p-Acetamidobenzene ester",
            "c) Ethyl mercaptan to phthalate esters",
            "d) Chloramphenicol to palmitate ester",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 230,
        "Question": "Which of the following reduces the pain of injection?",
        "Options": [
            "a) If the drug precipitates",
            "b) If the drug penetrates to the surrounding areas",
            "c) If the solution is strongly acidic",
            "d) More water-soluble drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 231,
        "Question": "Which one of these is the best way to preserve drugs for intravenous use?",
        "Options": [
            "a) Lyophilisation",
            "b) Drying",
            "c) Freezing",
            "d) In solution form",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 232,
        "Question": "Why carbenicillin cannot be given orally?",
        "Options": [
            "a) Tastes bad",
            "b) Bad odour",
            "c) Degraded by saliva",
            "d) Hydrolysed easily",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 233,
        "Question": "Why lipophilic drugs are absorbed easily?",
        "Options": [
            "a) Less hydrolysed",
            "b) Favours passive diffusion",
            "c) Dissolution rate high",
            "d) Can easily merge with the cell membrane",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 234,
        "Question": "Which of the following is not a disadvantage of site-specific drug delivery?",
        "Options": [
            "a) May lead to toxic effects on other non-target tissues",
            "b) May get diluted",
            "c) Less distribution time",
            "d) No penetrable to the target tissue",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 235,
        "Question": "Which of the following will not be a limitation for prodrug design?",
        "Options": [
            "a) Formation of toxic product",
            "b) An inert carrier can be cleaved off forming toxic product",
            "c) Product cleaving off before reaching the target site",
            "d) The cleaving of the carrier is also site-specific",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 236,
        "Question": "What is the prodrug of Trichloroethanol Cl3C-CH2OH?",
        "Options": [
            "a) <img src=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14a.png\" alt=\"drug-biotechnology-questions-answers-applications-prodrug-q14a\" width=\"411\" height=\"65\" class=\"alignnone size-full wp-image-250545\" srcset=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14a.png 411w, https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14a-300x47.png 300w\" sizes=\"(max-width: 411px) 100vw, 411px\" />",
            "b)   <img src=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14b.png\" alt=\"drug-biotechnology-questions-answers-applications-prodrug-q14b\" width=\"388\" height=\"65\" class=\"alignnone size-full wp-image-250546\" srcset=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14b.png 388w, https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14b-300x50.png 300w\" sizes=\"(max-width: 388px) 100vw, 388px\" />",
            "c)  <img src=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14c.png\" alt=\"drug-biotechnology-questions-answers-applications-prodrug-q14c\" width=\"405\" height=\"61\" class=\"alignnone size-full wp-image-250547\" srcset=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14c.png 405w, https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14c-300x45.png 300w\" sizes=\"(max-width: 405px) 100vw, 405px\" />",
            "d)   <img src=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14d.png\" alt=\"drug-biotechnology-questions-answers-applications-prodrug-q14d\" width=\"388\" height=\"60\" class=\"alignnone size-full wp-image-250548\" srcset=\"https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14d.png 388w, https://www.sanfoundry.com/wp-content/uploads/2019/10/drug-biotechnology-questions-answers-applications-prodrug-q14d-300x46.png 300w\" sizes=\"(max-width: 388px) 100vw, 388px\" />",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 237,
        "Question": "How to prevent hepatic first-pass metabolism for corticosteroids?",
        "Options": [
            "a) Providing intravenously",
            "b) Providing orally",
            "c) Form esters and ether products",
            "d) By enhancing lipophilicity",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 238,
        "Question": "Which one of the following is the principal organ for drug excretion?",
        "Options": [
            "a) Lungs",
            "b) Liver",
            "c) Kidneys",
            "d) Sweat glands",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 239,
        "Question": "Compounds excreted in bile is classified into 3 categories. Which one of the following does not come under the categories?",
        "Options": [
            "a) Drugs with bile/plasma concentration ratio approximately 1",
            "b) Drugs with bile/plasma concentration ratio between 10-1000",
            "c) Drugs with bile/plasma concentration ratio of less than 1",
            "d) Drugs with bile/plasma concentration ratio above 1000",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 240,
        "Question": "What is the molecular weight cut off for biliary excretion?",
        "Options": [
            "a) Less than 300 Dalton",
            "b) More than 300 Dalton",
            "c) Less than 200 Dalton",
            "d) More than 200 Dalton",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 241,
        "Question": "What is the equation for biliary clearance?",
        "Options": [
            "a) No such equation is there",
            "b) Biliary excretion rate/ plasma drug concentration",
            "c) Plasma drug concentration / biliary excretion rate",
            "d) Plasma drug concentration / Bile flow * biliary drug concentration",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 242,
        "Question": "For a certain drug, the bile flow rate is 0.7 ml/mm, the biliary drug concentration is 2g/ml and the plasma drug concentration is 0.8g/ml. What will be the bile clearance?",
        "Options": [
            "a) 1.50 ml/mm",
            "b) 1.75 ml/mm",
            "c) 2.75 ml/mm",
            "d) 3 ml/mm",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 243,
        "Question": "Which compounds are excreted through the lungs?",
        "Options": [
            "a) Lipophilic",
            "b) Gaseous",
            "c) Liquid and hydrophilic",
            "d) Solid less than 100 Dalton",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 244,
        "Question": "What is the pH of the milk secreted by human mothers?",
        "Options": [
            "a) 6.4-7.6",
            "b) 5.4-6.6",
            "c) 7-8",
            "d) 6-7",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 245,
        "Question": "What is the mechanism of drug excretion for skin excretion?",
        "Options": [
            "a) Active secretion",
            "b) Glomerular secretion",
            "c) Passive diffusion",
            "d) Passive reabsorption",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 246,
        "Question": "What is the mechanism of drug excretion for biliary excretion?",
        "Options": [
            "a) Active secretion",
            "b) Glomerular secretion",
            "c) Passive diffusion",
            "d) Passive reabsorption",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 247,
        "Question": "Which of the following is not a factor influencing pulmonary excretion?",
        "Options": [
            "a) Pulmonary blood flow",
            "b) The solubility of volatile substance",
            "c) Rate of respiration",
            "d) Heart rate",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 248,
        "Question": "How is renal clearance expressed mathematically?",
        "Options": [
            "a) Rate of urinary excretion/plasma drug concentration",
            "b) Plasma drug concentration/rate of urinary excretion",
            "c) 1/ Plasma drug concentration",
            "d) 1/rate of urinary excretion",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 249,
        "Question": "What is the driving force for glomerular filtration?",
        "Options": [
            "a) Concentration gradient",
            "b) Hydrostatic pressure of plasma",
            "c) High amount of aqueous pores",
            "d) Hydrostatic pressure of blood flow",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 250,
        "Question": "Which of the following compounds are used as agents to determine Glomerular Filtration Rate?",
        "Options": [
            "a) Calcium ion",
            "b) Albumin",
            "c) Creatinine",
            "d) Calcium carbonate",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 251,
        "Question": "What is total systemic clearance?",
        "Options": [
            "a) Sum of clearance from kidney",
            "b) Sum of clearance from kidney and liver",
            "c) Sum of clearance form non-renal clearances",
            "d) Sum of renal and non-renal clearances",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 252,
        "Question": "What is the equation for clearance?",
        "Options": [
            "a) Elimination rate / plasma drug concentration",
            "b) Plasma drug concentration/elimination rate",
            "c) 1 / Plasma drug concentration",
            "d) 1 / Elimination rate",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 253,
        "Question": "What will be the elimination rate if the clearance is 130ml/min and drug concentration is 0.8 g/ml?",
        "Options": [
            "a) 104g/min",
            "b) 140g/min",
            "c) 130g/min",
            "d) 100g/min",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 254,
        "Question": "What will be the renal clearance if the rate of urinary excretion is 625 ml/min and plasma drug concentration is 4.2 ng/ml?",
        "Options": [
            "a) 148.80ml2/ng min",
            "b) 150ml2/ng min",
            "c) 152ml2/ng min",
            "d) 140ml2/ng min",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 255,
        "Question": "How renal clearance ratio is expressed?",
        "Options": [
            "a) Renal clearance of creatinine / renal clearance of the drug",
            "b) 1/renal clearance of the drug",
            "c) Renal clearance of drug/ renal clearance of creatinine",
            "d) 1/renal clearance of creatinine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 256,
        "Question": "What will be the renal clearance ratio of a drug whose renal clearance is 40ml/min and the clearance of creatinine is 95ml/min?",
        "Options": [
            "a) 0.421",
            "b) 2.38",
            "c) 0.010",
            "d) 0.025",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 257,
        "Question": "How do you calculate the rate of excretion by kidneys?",
        "Options": [
            "a) Rate of filtration – the rate of secretion – Rate of absorption",
            "b) Rate of filtration + rate of secretion – Rate of absorption",
            "c) Rate of filtration + rate of secretion + Rate of absorption",
            "d) Rate of filtration – the rate of secretion + Rate of absorption",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 258,
        "Question": "What will be the rate of filtration if the rate of secretion is 0.9 ml/ sec, rate of reabsorption is 0.2 ml/sec and the rate of excretion is 2ml/sec for a particular drug?",
        "Options": [
            "a) 3ml/sec",
            "b) 0.3ml/sec",
            "c) 1ml/sec",
            "d) 1.3ml/sec",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 259,
        "Question": "Which of the following is not a factor of renal excretion?",
        "Options": [
            "a) Blood flow to the kidneys",
            "b) Urine pH",
            "c) Blood pH",
            "d) Disease state",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 260,
        "Question": "Which of the following is not a physicochemical factor of drug that can affect the renal excretion?",
        "Options": [
            "a) Molecular size",
            "b) Disintegration rate",
            "c) pKa of the drug",
            "d) Lipid solubility",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 261,
        "Question": "Which drugs cannot be filtered through glomerulus?",
        "Options": [
            "a) Drugs bound to plasma proteins",
            "b) Unbound",
            "c) Free drug",
            "d) Below molecular weight of 300 Dalton",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 262,
        "Question": "Which one is the correct equation to calculate the fraction of unbound drug in plasma?",
        "Options": [
            "a) Concentration of unbound drug in plasma / total plasma concentration of drug",
            "b) Total plasma concentration of drug / Concentration of unbound drug in plasma",
            "c) 1/Concentration of unbound drug in plasma",
            "d) 1/total plasma concentration of drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 263,
        "Question": "What will be the fraction of unbound drug if the unbound drug concentration is 0.99 g/ml and total plasma concentration is 160 g/ml?",
        "Options": [
            "a) 0.006",
            "b) 1.61",
            "c) 0.618",
            "d) 0.010",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 264,
        "Question": "What will be the unbound drug concentration if the unbound drug fraction is 0.52 and the total plasma concentration is 140 g/ml?",
        "Options": [
            "a) 80 g/ml",
            "b) 82.8 g/ml",
            "c) 70 g/ml",
            "d) 72.8 g/ml",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 265,
        "Question": "Which of the following promotes excretion of acidic drugs?",
        "Options": [
            "a) Citrates",
            "b) Ammonium chloride",
            "c) Methionine",
            "d) Ascorbic acid",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 266,
        "Question": "Which of the following promotes the excretion of basic drugs?",
        "Options": [
            "a) Tartarates",
            "b) Citrates",
            "c) Bicarbonates",
            "d) Ammonium chloride",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 267,
        "Question": "This is the equation for the calculation of creatinine clearance. Which age group does the Clcr = 0.48 H / Scr *[W/70]0.7 formula belong to?",
        "Options": [
            "a) 1-6 years",
            "b) 1-20 years",
            "c) Males above 20 years",
            "d) Females above 20 years",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 268,
        "Question": "This is the equation for the calculation of creatinine clearance. Which age group does the Clcr = (140 – Age) W / 72 * Scr formula belong to?",
        "Options": [
            "a) 1-6 years",
            "b) 1-20 years",
            "c) Males above 20 years",
            "d) Females above 20 years",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 269,
        "Question": "This is the equation for the calculation of creatinine clearance. Which age group does the Clcr = (140 – Age) W / 85 * Scr formula belong to?",
        "Options": [
            "a) 1-6 years",
            "b) 1-20 years",
            "c) Males above 20 years",
            "d) Females above 20 years",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 270,
        "Question": "A girl with age 21 has height 240cm, weight 55kg, serum creatinine of 0.8mg will have ______________ creatinine clearance.",
        "Options": [
            "a) 80 ml/min",
            "b) 90 ml/min",
            "c) 96.25 ml/min",
            "d) 85 ml/min",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 271,
        "Question": "An adult male with age 22 has height 240cm, weight 85kg, serum creatinine of 0.8mg will have ______________ creatinine clearance.",
        "Options": [
            "a) 150 ml/min",
            "b) 160 ml/min",
            "c) 170.13 ml/min",
            "d) 174.131 ml/min",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 272,
        "Question": "Which creatinine clearance value shows moderate renal failure?",
        "Options": [
            "a) 120-130 ml/min",
            "b) 20-50 ml/min",
            "c) Below 10 ml/min",
            "d) 70-80 ml/min",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 273,
        "Question": "Which creatinine clearance value shows severe renal failure?",
        "Options": [
            "a) 120-130 ml/min",
            "b) 20-50 ml/min",
            "c) Below 10 ml/min",
            "d) 70-80 ml/min",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 274,
        "Question": "Which kind of membrane is used in haemodialysis?",
        "Options": [
            "a) Artificial Semipermeable membrane",
            "b) Permeable membrane",
            "c) Natural semipermeable membrane of the peritoneal cavity",
            "d) Artificial permeable membrane",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 275,
        "Question": "Which kind of membrane is used in haemodialysis?",
        "Options": [
            "a) Artificial Semipermeable membrane",
            "b) Permeable membrane",
            "c) Natural semipermeable membrane of peritoneal cavity",
            "d) Artificial permeable membrane",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 276,
        "Question": "Which of the following will not be a factor governing the removal of substances through dialysis?",
        "Options": [
            "a) Molecular weight",
            "b) Water solubility",
            "c) Disintegration time",
            "d) Protein binding",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 277,
        "Question": "The time period for which the plasma concentration of drug remains above minimum effective concentration is known as ______________",
        "Options": [
            "a) Onset of time",
            "b) Onset of action",
            "c) Duration of drug of action",
            "d) Therapeutic range",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 278,
        "Question": "Which of the following is not a mechanism for pharmacokinetic analysis?",
        "Options": [
            "a) Compartment analysis",
            "b) Non compartment analysis",
            "c) Physiologic modeling",
            "d) Human model",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 279,
        "Question": "In which of the following models the body is considered to be composed of several compartments?",
        "Options": [
            "a) Compartment model",
            "b) Noncompartment model",
            "c) Physiologic model",
            "d) Human model",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 280,
        "Question": "In which of the model peripheral compartments are connected to a central compartment?",
        "Options": [
            "a) Compartment model",
            "b) Caternary model",
            "c) Physiologic model",
            "d) Mammillary model",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 281,
        "Question": "Which organs will make up the peripheral compartment?",
        "Options": [
            "a) Lungs",
            "b) Liver",
            "c) Kidneys",
            "d) Pancreas",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 282,
        "Question": "In which model compartments are joined in series?",
        "Options": [
            "a) Compartment model",
            "b) Caternary model",
            "c) Physiologic model",
            "d) Mammillary model",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 283,
        "Question": "Which of the following is not a characteristic of the caternary compartment model?",
        "Options": [
            "a) It gives a visual representation of various rate processes in drug disposition",
            "b) It shows how many rate constants are necessary",
            "c) Compartments and parameters bear a relationship with physiologic functions",
            "d) Useful in predicting drug",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 284,
        "Question": "In noncompartmental analysis, Mean residence time is equal to _____________",
        "Options": [
            "a) The area under the first moment curve/area under the zero moment curve",
            "b) The area under the zero moment’s curve/area under the first moment curve",
            "c) 1 / Area under the first-moment curve",
            "d) 1/ Area under the zero moment curve",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 285,
        "Question": "Which pharmacokinetic model is drawn on the basis of anatomic and physiologic data?",
        "Options": [
            "a) Compartment model",
            "b) Caternary model",
            "c) Physiologic model",
            "d) Mammillary model",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 286,
        "Question": "Which of the following will be a disadvantage for the physiologic model?",
        "Options": [
            "a) Prediction of drug concentration in various body regions",
            "b) Correlation of data in several animal species",
            "c) Obtaining experimental data for each of the organs",
            "d) The model gives an exact description of the drug concentration-time profile for any organ",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 287,
        "Question": "Which model is also known as membrane permeation rate limited?",
        "Options": [
            "a) Physiologic model",
            "b) Compartment model",
            "c) Noncompartment model",
            "d) Mammillary model",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 288,
        "Question": "What does the word “open” mean in the one compartment open model?",
        "Options": [
            "a) The drug easily enters",
            "b) The drug readily mixes with the blood",
            "c) Unidirectional input and output",
            "d) Easy absorption",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 289,
        "Question": "How much time does an intravenously administered drug take to complete a complete circulation?",
        "Options": [
            "a) 5-8 min",
            "b) 7-10 min",
            "c) 1-3 min",
            "d) 1 min",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 290,
        "Question": "In the equation log C = log Co – KEt/2.303, what does Co stand for _______",
        "Options": [
            "a) Plasma drug concentration after 60 min of i.v. injection",
            "b) Plasma drug concentration after 15 min of i.v. injection",
            "c) Plasma drug concentration after 30 min of i.v. injection",
            "d) Plasma drug concentration immediately after i.v. injection",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 291,
        "Question": "What is meant by elimination half-life?",
        "Options": [
            "a) Time take for half of the amount of drug to get completely eliminated from only the organs",
            "b) Time take for half of the amount of drug to get completely eliminated from only blood",
            "c) Time take for half of the amount of drug to get completely eliminated from only plasma",
            "d) Time take for half of the amount of drug to get completely eliminated from the body as well as plasma",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 292,
        "Question": "What is the equation to find out the apparent volume of distribution?",
        "Options": [
            "a) Amount of drug in the body/plasma drug concentration",
            "b) Plasma drug concentration/amount of drug in the body",
            "c) 1 / plasma drug concentration",
            "d) 1 / Amount of drug in the body",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 293,
        "Question": "The i.v. bolus dosage is 500mg and the plasma drug concentration is 0.8 mg/ml. What should be the volume of distribution?",
        "Options": [
            "a) 625 mg/ml",
            "b) 625 l",
            "c) 625 ml",
            "d) 0.0016 mg/ml",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 294,
        "Question": "To have a plasma distribution value of 900 ml and plasma drug concentration to be 1.2 mg/ml what should be the amount of drug that should be given to the patient?",
        "Options": [
            "a) 1080 ml",
            "b) 1080 g",
            "c) 1080 mg",
            "d) 1g/ml",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 295,
        "Question": "What is the equation to find out hepatic clearance?",
        "Options": [
            "a) Plasma drug concentration/rate of elimination by the kidney",
            "b) Rate of elimination by kidney/plasma drug concentration",
            "c) 1 / rate of elimination by the kidney",
            "d) 1 / plasma drug concentration",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 296,
        "Question": "Which organs comprise the central compartment in a two compartment model?",
        "Options": [
            "a) Muscles",
            "b) Skin",
            "c) Adipose",
            "d) Liver",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 297,
        "Question": "Which organ comprises the peripheral compartment in a two compartment model?",
        "Options": [
            "a) Liver",
            "b) Lungs",
            "c) Kidneys",
            "d) Muscles",
            ""
        ],
        "Answer": "Answer:  d"
    },
    {
        "id": 298,
        "Question": "Which of the following is not a category of 2 compartment model?",
        "Options": [
            "a) Two compartment model with elimination from the central compartment",
            "b) Two compartment model with elimination from the peripheral compartment",
            "c) Two compartment model with elimination from only plasma and blood",
            "d) Two compartment model with elimination from both the compartments",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 299,
        "Question": "Which of the following creates nonlinearity in drug distribution and not in drug absorption?",
        "Options": [
            "a) When absorption is solubility or dissolution rate-limited",
            "b) When absorption involves carrier-mediated transport systems",
            "c) When a presystemic gut wall or hepatic metabolism attains saturation",
            "d) Saturation of binding sites on plasma proteins",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 300,
        "Question": "Which one of these are correct Michaelis-Menten equation?",
        "Options": [
            "a) –dC/dt = Vmax C/Km+C",
            "b) dC/dt = Vmax C/Km+C",
            "c) –dC/dt = Vmax C/Km",
            "d) –dC/dt = Km+C/Vmax C",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 301,
        "Question": "What is bioavailability?",
        "Options": [
            "a) The time of absorption of the drug from its dosage form",
            "b) The rate of absorption of the unchanged drug from its dosage form",
            "c) The time of absorption of the unchanged drug from its dosage form",
            "d) The rate of absorption of the drug from its dosage form",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 302,
        "Question": "What is the equation of bioavailable fraction?",
        "Options": [
            "a) 1/Bioavailable dose",
            "b) 1/Administered dose",
            "c) Bioavailable dose/Administered dose",
            "d) Administered dose/Bioavailable dose",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 303,
        "Question": "Which of the following is not an objective of bioavailability studies?",
        "Options": [
            "a) Primary stages of development of suitable dosage form for new drug",
            "b) Determination of the influence of excipients, patient-related factors, etc",
            "c) Development of new formulations of the existing drugs",
            "d) Control the quantity of the drug to be administered",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 304,
        "Question": "Which of the following is the pharmacodynamics method of studying bioavailability?",
        "Options": [
            "a) Acute pharmacologic response",
            "b) Plasma-level time studies",
            "c) Urinary excretion studies",
            "d) Stool excretion studies",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 305,
        "Question": "Which of the following is not an important parameter of plasma level time studies?",
        "Options": [
            "a) Cmax",
            "b) Tax",
            "c) The area under the plasma level-time curve",
            "d) Steady state level",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 306,
        "Question": "What is the equation for bioavailability?",
        "Options": [
            "a) [AUC]std Dstd τtest / [AUC]test Dtest τstd",
            "b) [AUC]test Dtest τstd / [AUC]std Dstd τtest",
            "c) [AUC]test Dstd τtest / [AUC]std Dtest τstd",
            "d) 1 / [AUC]std Dtest τstd",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 307,
        "Question": "Which of the following will not be a parameter that should be examined for urinary excretion data?",
        "Options": [
            "a) (dXu/dt)max",
            "b) (tu)max",
            "c) Xu",
            "d) Cmax",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 308,
        "Question": "Which of the following is not measured in acute pharmacological response study?",
        "Options": [
            "a) ECG",
            "b) EEG",
            "c) Pupil diameter",
            "d) Serum drug level",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 309,
        "Question": "What is bioequivalence?",
        "Options": [
            "a) Comparison between 3-year-old drugs to the same new drug",
            "b) Comparison between drugs to another drug",
            "c) Comparison between a drug’s specific characteristics to a defined set of standards",
            "d) Comparison between two or 3 characteristics of a drug to the same characteristics of a different drug",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 310,
        "Question": "What is the chemical equivalence?",
        "Options": [
            "a) Two or more drug products contain the same labeled chemical substance in the same amount",
            "b) Two or more drug products contain the same labeled chemical substance in different quantity",
            "c) Two or more drug products contain different labeled chemical substance giving the same therapeutic effect",
            "d) Two or more drug products contain the same labeled chemical substance giving a different therapeutic effect",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 311,
        "Question": "What is pharmaceutic equivalence?",
        "Options": [
            "a) Two or more drug products contain the same labeled chemical substance in the same amount",
            "b) Two or more drug products are identical in quality, purity, uniformity, disintegration, dissolution",
            "c) Two or more drug products contain different labeled chemical substance giving the same therapeutic effect",
            "d) Two or more drug products contain the same labeled chemical substance giving a different therapeutic effect",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 312,
        "Question": "What is bioequivalence?",
        "Options": [
            "a) Drug substance reaches the systemic circulation at the same rate in two or more identical dosage",
            "b) Two or more drug products contain the same labeled chemical substance in different quantity",
            "c) Two or more drug products contain different labeled chemical substance giving the same therapeutic effect",
            "d) Two or more drug products contain the same labeled chemical substance giving a different therapeutic effect",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 313,
        "Question": "What is therapeutic equivalence?",
        "Options": [
            "a) Two or more drug products contain the same labeled chemical substance in the same amount",
            "b) Two or more drug products contain the same labeled chemical substance in different quantity",
            "c) Two or more drug products contain the same labeled chemical substance giving the same therapeutic effect",
            "d) Two or more drug products contain the same labeled chemical substance giving a different therapeutic effect",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 314,
        "Question": "On which individuals study of newly invented medicines are not done?",
        "Options": [
            "a) Pregnant and elderly",
            "b) Fasting person",
            "c) Healthy person",
            "d) Adult male",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 315,
        "Question": "What should be the disadvantage of cross over study on volunteers?",
        "Options": [
            "a) Minimize the intersubject variability in plasma drug levels",
            "b) Minimize the carry-over effect",
            "c) Minimizes variations due to time effect",
            "d) Takes a lot of time to get the result of the study",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 316,
        "Question": "Which of the following is not an approach for overcoming bioavailability problems?",
        "Options": [
            "a) Pharmaceutic approach",
            "b) Pharmacokinetic approach",
            "c) Biologic approach",
            "d) Partition coefficient approach",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 317,
        "Question": "What will be the particle size after micronization of drugs?",
        "Options": [
            "a) 1-10 micron",
            "b) 10-20 micron",
            "c) 20-30 micron",
            "d) 1-5 micron",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 318,
        "Question": "What is the principle behind the use of surfactants?",
        "Options": [
            "a) Reducing the size of solid drug particles",
            "b) Enhancing the dissolution rate by promoting wetting",
            "c) Improving solubility",
            "d) Alter the pH of the microenvironment",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 319,
        "Question": "How pH alteration of the drug microenvironment is done?",
        "Options": [
            "a) Altering the pH while the administration",
            "b) In situ salt formation",
            "c) Altering the pH of the tissue",
            "d) Formulating the drug in such a way that it gets activated only when it reaches the tissue pH",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 320,
        "Question": "Which one of the following is used for selective adsorption on insoluble carriers of the drugs?",
        "Options": [
            "a) Freeze drying",
            "b) Organic solvent",
            "c) Inorganic clays like bentonite",
            "d) Creating metastable polymorphs",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 321,
        "Question": "Which of the following is used in the solvent deposition method of enhancing bioavailability?",
        "Options": [
            "a) Freeze drying",
            "b) Organic solvent",
            "c) Inorganic clays like bentonite",
            "d) Creating metastable polymorphs",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 322,
        "Question": "Which of the following is used in solid solutions method of enhancing bioavailability?",
        "Options": [
            "a) Highly water-soluble compound",
            "b) Organic solvent",
            "c) Inorganic clays like bentonite",
            "d) Creating metastable polymorphs",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 323,
        "Question": "Which of the following is used in molecular encapsulation of drugs for enhancing bioavailability?",
        "Options": [
            "a) Highly water-soluble compound",
            "b) Cyclodextrin",
            "c) Inorganic clays like bentonite",
            "d) Creating metastable polymorphs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 324,
        "Question": "What is the function of local anesthetics?",
        "Options": [
            "a) Suppress the activity of the brain",
            "b) Render a specific portion insensitive to pain",
            "c) Suppress the function of a whole organ",
            "d) Make the patient’s full body insensitive to pain",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 325,
        "Question": "Which of the following is the parenteral application of local anesthetics?",
        "Options": [
            "a) When applied to the mucous membrane",
            "b) When applied to the skin",
            "c) When injected to CNS through spinal injection techniques",
            "d) Using ophthalmic drops",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 326,
        "Question": "Which of the following are natural local anesthetics?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Clove oil",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 327,
        "Question": "Which of the following is synthetic nitrogenous local anesthetic?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Clove oil",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 328,
        "Question": "Which of the following is synthetic non-nitrogenous anesthetic?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Clove oil",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 329,
        "Question": "Apart from natural, synthetic, synthetic non-nitrogenous, which of the following is also a local anesthetic?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Clove oil",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 330,
        "Question": "Which of the following is the pharmacological action of local anesthetics?",
        "Options": [
            "a) Reversible block of conduction in nerve",
            "b) Class II antidysrhythmic like action",
            "c) Contraction of smooth muscle",
            "d) Excitation of neuro-muscular transmission in skeletal muscle",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 331,
        "Question": "What does membrane expansion theory states?",
        "Options": [
            "a) The mechanism is not similar to the general anesthetics",
            "b) Does not rely upon the lipophilic moiety of drugs",
            "c) The molecules of the agent get incorporated into the lipid membrane",
            "d) Causes nerve polarization",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 332,
        "Question": "What does the specific receptor theory state?",
        "Options": [
            "a) Local anesthetics bind to various receptors",
            "b) Produces chemical changes to the receptors",
            "c) Tries to open all the closed sodium gates",
            "d) Binding produces conformational changes",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 333,
        "Question": "Which of the following factor do not affect the absorption of local anesthetics?",
        "Options": [
            "a) Vasodilating ability of drug",
            "b) Volume and concentration",
            "c) Vascularity of the tissue",
            "d) Presence of vasodilator",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 334,
        "Question": "Which is the first local anesthetic?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Clove oil",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 335,
        "Question": "Which of the following is being used in dentistry when patients have an allergy from procaine?",
        "Options": [
            "a) Cocaine",
            "b) Benzocaine",
            "c) Benzyl alcohol",
            "d) Procaine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 336,
        "Question": "Which of the following is amide type drug?",
        "Options": [
            "a) Lignocaine",
            "b) Cocaine",
            "c) Procaine",
            "d) Benzocaine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 337,
        "Question": "Which of the following is topical with high concentration?",
        "Options": [
            "a) Lignocaine",
            "b) Cocaine",
            "c) Procaine",
            "d) Benzocaine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 338,
        "Question": "Which of the following will work as an anesthetic?",
        "Options": [
            "a) Pantoprazole",
            "b) Amlodipine",
            "c) Cocaine",
            "d) Mannitol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 339,
        "Question": "In which of the stage of general anesthesia the movement of the diaphragm is the highest?",
        "Options": [
            "a) Plane 1 of stage III",
            "b) Plane 2 of stage III",
            "c) Plane 3 of stage III",
            "d) Plane 4 of stage III",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 340,
        "Question": "In which stage of general anesthesia the patient starts vomiting?",
        "Options": [
            "a) Stage I ending",
            "b) Stage II ending",
            "c) Stage III ending",
            "d) Stage IV ending",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 341,
        "Question": "What is the function of general anesthetics?",
        "Options": [
            "a) Render a specific portion of the body insensitive to pain",
            "b) Render a full body of the patient insensitive to pain",
            "c) Render a specific organ of the body insensitive to pain",
            "d) Render a specific CNS of the body insensitive to pain",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 342,
        "Question": " Which of the following is not an inhaled anesthetics?",
        "Options": [
            "a) Haloethane",
            "b) Enflurane",
            "c) Isoflurane",
            "d) Diflurane",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 343,
        "Question": "Which of the following order of inducing cardiac arrhythmias of inhaled anesthetics is correct?",
        "Options": [
            "a) F < Br < I < Cl",
            "b) F < Cl < Br < I",
            "c) F > Cl > Br > I",
            "d) Br < I < F < Cl",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 344,
        "Question": "Which of the following is incorrect if we are talking about the essential components of general anesthesia?",
        "Options": [
            "a) Analgesia",
            "b) Hypnosis",
            "c) Depression of spinal motor reflexes",
            "d) Muscle contraction",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 345,
        "Question": "What does the lipid theory tell?",
        "Options": [
            "a) Lower the solubility of the anesthetic in water higher potency it has",
            "b) Higher the solubility of the anesthetic in water higher potency it has",
            "c) Higher the solubility of the anesthetic in oil higher potency it has",
            "d) Lower the solubility of the anesthetic in oil higher potency it has",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 346,
        "Question": "What does the protein (receptor) theory tells us?",
        "Options": [
            "a) Anesthetic potency is related to the ability of anesthetic to inhibit enzyme activity",
            "b) Higher the solubility of the anesthetic in water higher potency it has",
            "c) Higher the solubility of the anesthetic in oil higher potency it has",
            "d) Lower the solubility of the anesthetic in oil higher potency it has",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 347,
        "Question": "What are opioid analgesics?",
        "Options": [
            "a) Render a specific portion of the body insensitive to pain",
            "b) Render the full body of the patient insensitive to pain",
            "c) Render insensitive to pain by binding to opioid receptors",
            "d) Render a specific CNS of the body insensitive to pain",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 348,
        "Question": "Which of the following are natural opiates?",
        "Options": [
            "a) Codeine",
            "b) Oxycodone",
            "c) Fentanyl",
            "d) Endomorphins",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 349,
        "Question": "Which of the following are semi-synthetic opiates?",
        "Options": [
            "a) Codeine",
            "b) Oxycodone",
            "c) Fentanyl",
            "d) Endomorphins",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 350,
        "Question": "Which of the following are fully synthetic opioids?",
        "Options": [
            "a) Codeine",
            "b) Oxycodone",
            "c) Fentanyl",
            "d) Endomorphins",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 351,
        "Question": "Which of the following are endogenous opioid peptides?",
        "Options": [
            "a) Codeine",
            "b) Oxycodone",
            "c) Fentanyl",
            "d) Endomorphins",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 352,
        "Question": "How does the general opioids function?",
        "Options": [
            "a) Render a specific portion of the body insensitive to pain",
            "b) Render the full body of the patient insensitive to pain",
            "c) Render insensitive to pain by decreasing the pain threshold",
            "d) Render a specific CNS of the body insensitive to pain",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 353,
        "Question": "Which of the following side effects of morphine is the most dangerous?",
        "Options": [
            "a) Excitation",
            "b) Nausea",
            "c) Constipation",
            "d) Tolerance and dependence",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 354,
        "Question": "What is opiophobia?",
        "Options": [
            "a) Fear of opioid plant",
            "b) Fear of drugs",
            "c) Fear of prescribing opioid drugs",
            "d) Fear of anesthesia",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 355,
        "Question": "Which of the following is the short-term effect of heroin?",
        "Options": [
            "a) Euphoria",
            "b) Infection of the heart lining",
            "c) Addiction",
            "d) Decreased function of the liver",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 356,
        "Question": "Which of the following is the long term effect of heroine?",
        "Options": [
            "a) Dryness of mouth",
            "b) Collapsed veins",
            "c) Muscle weakness",
            "d) Euphoria",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 357,
        "Question": "What is the antagonist for heroin?",
        "Options": [
            "a) Naloxone",
            "b) Oxycodone",
            "c) Fentanyl",
            "d) Endomorphins",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 358,
        "Question": "Which of the following Fentanyl analogues is ultra-short acting analgesic?",
        "Options": [
            "a) Alfentanyl",
            "b) Sufentanil",
            "c) Remifentanil",
            "d) Carfentanil",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 359,
        "Question": "Which of the following fentanyl analogue is used in heart surgery?",
        "Options": [
            "a) Alfentanyl",
            "b) Sufentanil",
            "c) Remifentanil",
            "d) Carfentanil",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 360,
        "Question": "Which of the following is the shortest acting fentanyl analogue?",
        "Options": [
            "a) Alfentanyl",
            "b) Sufentanil",
            "c) Remifentanil",
            "d) Carfentanil",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 361,
        "Question": "Which of the following fentanyl analogue is being used in veterinary practice?",
        "Options": [
            "a) Alfentanyl",
            "b) Sufentanil",
            "c) Remifentanil",
            "d) Carfentanil",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 362,
        "Question": "Which hormone is a major contributor to the symptoms of inflammation?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Bradykinin",
            "d) Leukotrienes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 363,
        "Question": "Which of the following promotes edema?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Bradykinin",
            "d) Prostaglandins",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 364,
        "Question": "Which hormone is a major contributor for pain during inflammation reaction?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Bradykinin",
            "d) Leukotrienes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 365,
        "Question": "Which hormone is a major contributor to chemotaxis while inflammation reaction?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Prostaglandins",
            "d) Leukotrienes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 366,
        "Question": "Which hormone is a major contributor for increasing vascular permeability during inflammation?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Bradykinin",
            "d) Leukotrienes",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 367,
        "Question": "Which hormone is a major contributor to vasodilation during inflammation reaction?",
        "Options": [
            "a) Histamine",
            "b) Serotonin",
            "c) Bradykinin",
            "d) Leukotrienes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 368,
        "Question": "Why the redness can be seen during inflammation?",
        "Options": [
            "a) Local blood vessel dilation",
            "b) Influx of plasma proteins, phagocytic cells into the tissue spaces",
            "c) Release of enzymes",
            "d) Increased of tissue pressure",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 369,
        "Question": "Why the Heat can be seen during inflammation?",
        "Options": [
            "a) Local blood vessel dilation",
            "b) Influx of plasma proteins, phagocytic cells into the tissue spaces",
            "c) Release of enzymes",
            "d) Increased of tissue pressure",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 370,
        "Question": "Why the swelling can be seen during inflammation?",
        "Options": [
            "a) Local blood vessel dilation",
            "b) Influx of plasma proteins, phagocytic cells into the tissue spaces",
            "c) Release of enzymes",
            "d) Increased of tissue pressure",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 371,
        "Question": "Why the pain can be felt during inflammation?",
        "Options": [
            "a) Local blood vessel dilation",
            "b) Influx of plasma proteins",
            "c) Release of enzymes and increased of tissue pressure",
            "d) Influx of phagocytic cells",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 372,
        "Question": "Which of the following drug is an indole derivative?",
        "Options": [
            "a) ASA",
            "b) Ibuprofen",
            "c) Phenylbutazone",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 373,
        "Question": "Which of the following drug is a Phenylpropionic acid derivative?",
        "Options": [
            "a) ASA",
            "b) Ibuprofen",
            "c) Phenylbutazone",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 374,
        "Question": "Which of the following is an example of salicylates?",
        "Options": [
            "a) ASA",
            "b) Ibuprofen",
            "c) Phenylbutazone",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 375,
        "Question": "Which is the predominant form of cyclooxygenase enzyme?",
        "Options": [
            "a) COX 1",
            "b) COX 2",
            "c) COX 3",
            "d) COX 4",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 376,
        "Question": "How does NSAIDs work?",
        "Options": [
            "a) Inhibit arachidonic acid",
            "b) Inhibit Endoperoxide intermediate",
            "c) Inhibit Prostaglandin and thromboxane synthesis",
            "d) Inhibit cyclooxygenase",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 377,
        "Question": "Which of the following has a half-life of 45 Hrs?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) Ibuprofen",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 378,
        "Question": "Which of the following has the same potency as ASA and better tolerated by patients?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) Ibuprofen",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 379,
        "Question": "Which of the following cannot be tolerated, rheumatoid arthritis patient?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) Ibuprofen",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 380,
        "Question": "Which of the following pyrazolone derivative’s has toxic side effects?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) Ibuprofen",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 381,
        "Question": "Which of the following is a pro-drug and related to indomethacin?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) Sulindac",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 382,
        "Question": "Which of the following is also known as “housekeeping enzyme”?",
        "Options": [
            "a) COX 1",
            "b) COX 2",
            "c) COX 3",
            "d) COX 4",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 383,
        "Question": "Which of the following responsible for inflammatory response mainly?",
        "Options": [
            "a) COX 1",
            "b) COX 2",
            "c) COX 3",
            "d) COX 4",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 384,
        "Question": "Why there are side effects of NSAIDs?",
        "Options": [
            "a) Inhibition of COX 1",
            "b) Inhibition of COX 2",
            "c) Inhibition of COX 3",
            "d) Inhibition of COX 4",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 385,
        "Question": "Which of the following has the least GI effect and derived from parent NSAIDs?",
        "Options": [
            "a) Piroxicam",
            "b) Phenylbutazone",
            "c) NO-NSAIDs",
            "d) Indomethacin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 386,
        "Question": "How does Eicosapentaenoic acid functions to decrease the inflammation rate?",
        "Options": [
            "a) Decrease Prostaglandin production",
            "b) Don’t form prostaglandin",
            "c) Induce the formation of prostaglandins at certain times",
            "d) The prostaglandins, thromboxane produced from EPA are less active",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 387,
        "Question": "What is dosage regimen?",
        "Options": [
            "a) The concentration of active agent in the drug formulation",
            "b) The manner in which the drug is given to old people",
            "c) The manner in which a drug is taken",
            "d) The manner in which drug given to child",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 388,
        "Question": "What is the optimal multiple dosage regimen?",
        "Options": [
            "a) The concentration of active agent in the drug formulation",
            "b) Dosage which maintains the plasma concentration within the therapeutic window.",
            "c) The manner in which a drug is taken",
            "d) The manner in which drug given to child",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 389,
        "Question": "On what basis the dose interval is calculated?",
        "Options": [
            "a) Active drug concentration in the formulation",
            "b) Half-life of the drug",
            "c) Duration of the disease",
            "d) Age of the patient",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 390,
        "Question": "What is fluctuation?",
        "Options": [
            "a) Cmax/Cmin",
            "b) Cmin / Cmax",
            "c) 1/Cmin",
            "d) 1/Cmax",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 391,
        "Question": "How do you calculate the ideal body weight for men?",
        "Options": [
            "a) 50 kg +- 1kg/2.5cm above or below 150 cm in height",
            "b) 45 kg +- 1kg/2.5cm above or below 150 cm in height",
            "c) 40 kg +- 1kg/2.5cm above or below 150 cm in height",
            "d) 35 kg +- 1kg/2.5cm above or below 150 cm in height",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 392,
        "Question": "How do you calculate the ideal body weight for a woman?",
        "Options": [
            "a) 50 kg +- 1kg/2.5cm above or below 150 cm in height",
            "b) 45 kg +- 1kg/2.5cm above or below 150 cm in height",
            "c) 40 kg +- 1kg/2.5cm above or below 150 cm in height",
            "d) 35 kg +- 1kg/2.5cm above or below 150 cm in height",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 393,
        "Question": "Which of the following drugs are lipid soluble?",
        "Options": [
            "a) Phenytoin",
            "b) Caffeine",
            "c) Digoxin",
            "d) Antibiotics",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 394,
        "Question": "Which of the following drugs get distributed to the same extent in both lean and adipose tissue?",
        "Options": [
            "a) Phenytoin",
            "b) Caffeine",
            "c) Digoxin",
            "d) Antibiotics",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 395,
        "Question": "Which of the following drugs can get distributed to the excess body space of obese patient?",
        "Options": [
            "a) Phenytoin",
            "b) Caffeine",
            "c) Digoxin",
            "d) Antibiotics",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 396,
        "Question": "Which of the following drug can get distributed in the excess body space?",
        "Options": [
            "a) Phenytoin",
            "b) Caffeine",
            "c) Digoxin",
            "d) Antibiotics",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 397,
        "Question": "Antihistamine drugs are antagonists for which receptor?",
        "Options": [
            "a) H1 receptor antagonist",
            "b) H2 receptor antagonist",
            "c) H3 receptor antagonist",
            "d) H4 receptor antagonist",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 398,
        "Question": "Which class of antibody is associated with an allergic reaction?",
        "Options": [
            "a) IgE",
            "b) IgA",
            "c) IgM",
            "d) IgG",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 399,
        "Question": "If both the parent has allergy how much percentage chance is there that the child will also get an allergy?",
        "Options": [
            "a) 20%",
            "b) 48%",
            "c) 70%",
            "d) 100%",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 400,
        "Question": "If one of the parents has allergy how much percentage probability is there that the child will also get allergy?",
        "Options": [
            "a) 20%",
            "b) 48%",
            "c) 70%",
            "d) 100%",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 401,
        "Question": " Which of the following enzyme is essential for the conversion of histidine to histamine?",
        "Options": [
            "a) Histidine amylase",
            "b) Histidine hydrolase",
            "c) Histidine decarboxylase",
            "d) Histidine phosphorylase",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 402,
        "Question": "Which of the following histamine receptor increase permeability during inflammation reaction?",
        "Options": [
            "a) H1 receptor",
            "b) H2 receptor",
            "c) H3 receptor",
            "d) H4 receptor",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 403,
        "Question": "Which of the following histamine receptor increases the release of gastric acid?",
        "Options": [
            "a) H1 receptor",
            "b) H2 receptor",
            "c) H3 receptor",
            "d) H4 receptor",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 404,
        "Question": "What causes the side effects of H1 receptor antihistamines?",
        "Options": [
            "a) Lack of selectivity of the H1 receptor",
            "b) Lack of selectivity anti-cholinergic activity",
            "c) Due to CNS depression",
            "d) Lack of selectivity of H1 receptor, anticholinergic effect, and CNS depression",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 405,
        "Question": "Which of the following is the first antihistamine?",
        "Options": [
            "a) Piperoxan",
            "b) Ethylenediamine",
            "c) Alkylamines",
            "d) Tricyclics",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 406,
        "Question": "What are the characteristics of 2nd generation h1 receptor antagonists?",
        "Options": [
            "a) Selective for peripheral H1 receptors",
            "b) Opposed to CNS H1 receptors",
            "c) Selective for peripheral H1 receptors and opposed to CNS receptors",
            "d) Selective to H1 receptors of CNS",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 407,
        "Question": "Which of the following drug are over the counter drug?",
        "Options": [
            "a) Loratidine",
            "b) Terfenadine",
            "c) Desloratidine",
            "d) Fexofenadine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 408,
        "Question": "Which of the following drug is of Ethylenediamine class?",
        "Options": [
            "a) Mepyramine",
            "b) Diphenhydramine",
            "c) Cyclizine",
            "d) Chlorphenamine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 409,
        "Question": "Which of the following drug is of Ethanolamine class?",
        "Options": [
            "a) Mepyramine",
            "b) Diphenhydramine",
            "c) Cyclizine",
            "d) Chlorphenamine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 410,
        "Question": "Which of the following drug is of Alkylamine class?",
        "Options": [
            "a) Mepyramine",
            "b) Diphenhydramine",
            "c) Cyclizine",
            "d) Chlorphenamine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 411,
        "Question": "Which of the following drug is of Piperazine class?",
        "Options": [
            "a) Mepyramine",
            "b) Diphenhydramine",
            "c) Cyclizine",
            "d) Chlorphenamine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 412,
        "Question": "What are diuretic agents?",
        "Options": [
            "a) Drugs that accelerate the rate of urine formation",
            "b) Drugs that accelerates heart rate",
            "c) A drug that accelerates breathing rate",
            "d) A drug that reduces heart rate",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 413,
        "Question": "Which of the following statement is false?",
        "Options": [
            "a) 20% to 25% of all sodium is reabsorbed into the bloodstream in the loop of Henle",
            "b) 5% to 10% of sodium is reabsorbed in the distal tubules",
            "c) 3% sodium is absorbed in collecting ducts",
            "d) 50% of sodium is absorbed in the glomerulus",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 414,
        "Question": "What is the site of action of the diuretic mannitol?",
        "Options": [
            "a) Proximal tubule",
            "b) Glomerulus",
            "c) Descending loop of Henle",
            "d) Distal Tubule",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 415,
        "Question": "What is the site of action of the diuretic Acetazolamide?",
        "Options": [
            "a) Proximal tubule",
            "b) Glomerulus",
            "c) Descending loop of Henle",
            "d) Distal tubule",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 416,
        "Question": "What is the site of action of the loop diuretics?",
        "Options": [
            "a) Proximal tubule",
            "b) Glomerulus",
            "c) Ascending loop of Henle",
            "d) Distal tubule",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 417,
        "Question": "What is the site of action of the diuretic thiazide diuretics?",
        "Options": [
            "a) Proximal tubule",
            "b) Glomerulus",
            "c) Descending loop of Henle",
            "d) Distal tubule",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 418,
        "Question": "What is the site of action of the potassium-sparing diuretics?",
        "Options": [
            "a) Proximal tubule",
            "b) Glomerulus",
            "c) Descending loop of Henle",
            "d) Distal tubule",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 419,
        "Question": "Which of the following can be treated by using Carbonic anhydrous inhibitor diuretics?",
        "Options": [
            "a) High altitude sickness and renal disease",
            "b) Edema and hypercalcemia",
            "c) Glaucoma and epilepsy",
            "d) Glaucoma and hypercalcemia",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 420,
        "Question": "Which of the following can be treated by using loop diuretics?",
        "Options": [
            "a) High altitude sickness and renal disease",
            "b) Hypertension and hypercalcemia",
            "c) Glaucoma and epilepsy",
            "d) Glaucoma and hypercalcemia",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 421,
        "Question": "Which of the following can be treated by using thiazide and thiazide-like diuretics?",
        "Options": [
            "a) High altitude sickness and renal disease",
            "b) Hypercalcemia",
            "c) Hepatic cirrhosis",
            "d) Glaucoma and hypercalcemia",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 422,
        "Question": "Which of the following will be used for a severe head injury?",
        "Options": [
            "a) Osmotic diuretics",
            "b) Loop diuretics",
            "c) Carbonic anhydrous inhibitor diuretics",
            "d) Potassium-sparing diuretics",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 423,
        "Question": "Which of the following diuretics should be used for hypercalcemia patients?",
        "Options": [
            "a) Osmotic diuretics",
            "b) Loop diuretics",
            "c) Carbonic anhydrous inhibitor diuretics",
            "d) Potassium-sparing diuretics",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 424,
        "Question": "Which of the following diuretics will you use when you have to have a rapid diuresis?",
        "Options": [
            "a) Osmotic diuretics",
            "b) Loop diuretics",
            "c) Carbonic anhydrous inhibitor diuretics",
            "d) Potassium-sparing diuretics",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 425,
        "Question": "We tell a person has a high blood pressure when the systolic pressure is ____________",
        "Options": [
            "a) More than 140 mm Hg",
            "b) More than 90 mm Hg",
            "c) More than 110 mm Hg",
            "d) More than 200 mm Hg",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 426,
        "Question": "We tell a person has a high blood pressure when the diastolic pressure is ____________",
        "Options": [
            "a) More than 140 mm Hg",
            "b) More than 90 mm Hg",
            "c) More than 110 mm Hg",
            "d) More than 200 mm Hg",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 427,
        "Question": "Which combination of systolic and diastolic pressure tells a person has stage 1 hypertension?",
        "Options": [
            "a) Less than 120 mm Hg Systolic and less than 80 mm Hg diastolic",
            "b) 120-139 mm Hg Systolic and 80-89 mm Hg diastolic",
            "c) 140-159 mm Hg Systolic and 90-99 mm Hg diastolic",
            "d) More than 160 mm Hg Systolic and more than 100 mm Hg diastolic",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 428,
        "Question": "Which combination of systolic and diastolic pressure tells a person has stage 2 hypertension?",
        "Options": [
            "a) Less than 120 mm Hg Systolic and less than 80 mm Hg diastolic",
            "b) 120-139 mm Hg Systolic and 80-89 mm Hg diastolic",
            "c) 140-159 mm Hg Systolic and 90-99 mm Hg diastolic",
            "d) More than 160 mm Hg Systolic and more than 100 mm Hg diastolic",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 429,
        "Question": "On which of the factor the blood pressure depends upon?",
        "Options": [
            "a) Nervous system",
            "b) Kidney function",
            "c) Fluid volume",
            "d) Hormonal change",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 430,
        "Question": "On which of the factor the blood pressure is affected by?",
        "Options": [
            "a) Nervous system",
            "b) Cardiac output",
            "c) Contractility",
            "d) Peripheral vascular resistance",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 431,
        "Question": "Which of the following is not a treatment for Hypertension?",
        "Options": [
            "a) 1st line treatment",
            "b) 2nd line treatment",
            "c) 3rd line treatment",
            "d) Intake of lots of protein rich food",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 432,
        "Question": "Which are the drugs for 1st line treatment of hypertension?",
        "Options": [
            "a) Diuretic",
            "b) Angiotensin-converting enzyme inhibitor",
            "c) Increase drug dose",
            "d) Need further studies",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 433,
        "Question": "Which are the drugs for 2nd line treatment of hypertension?",
        "Options": [
            "a) Diuretic",
            "b) Angiotensin-converting enzyme inhibitor",
            "c) Increase drug dose",
            "d) Need further studies",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 434,
        "Question": "Which are the drugs for 3rd line treatment of hypertension?",
        "Options": [
            "a) Diuretic",
            "b) Angiotensin-converting enzyme inhibitor",
            "c) Increase drug dose",
            "d) Need further studies",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 435,
        "Question": "Which should be done if the 3rd line treatment of hypertension is not enough for a patient?",
        "Options": [
            "a) Diuretic",
            "b) Angiotensin-converting enzyme inhibitor",
            "c) Increase drug dose",
            "d) Need further studies",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 436,
        "Question": "Where β1 beta receptors are found mostly in the body?",
        "Options": [
            "a) Liver",
            "b) Kidney",
            "c) Heart",
            "d) Lungs",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 437,
        "Question": "Which of the drug is a type of ACE inhibitor?",
        "Options": [
            "a) Captopril",
            "b) Irbesartan",
            "c) Amlodipine",
            "d) Furosemide",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 438,
        "Question": "What is the function of somatostatin?",
        "Options": [
            "a) Inhibits histamine and gastrin-releasing cells",
            "b) Activates histamine and gastrin realising cells",
            "c) Inhibits H+ secretion",
            "d) Ensures H+ secretion",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 439,
        "Question": "Which of the following receptor is closed by drug during a peptic ulcer?",
        "Options": [
            "a) H1",
            "b) H2",
            "c) Proton pump",
            "d) H2 and proton pump",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 440,
        "Question": "Which of the following drugs are H2 antihistamine?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Pirenzepine",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 441,
        "Question": "Which of the following drugs is Proton pump inhibitor?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Pirenzepine",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 442,
        "Question": "Which of the following drugs are Anticholinergics?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Pirenzepine",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 443,
        "Question": "Which of the following drugs is antacid?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Mg hydroxide",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 444,
        "Question": "Which of the following drugs are ulcer protectives?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Sucralfate",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 445,
        "Question": "Which of the following drugs is Anti-H. pyloric?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Amoxicillin",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 446,
        "Question": "Which of the following is a mucoprotective drug?",
        "Options": [
            "a) Cimetidine",
            "b) Omeprazole",
            "c) Sucralfate",
            "d) Misoprostol",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 447,
        "Question": "What is GERD?",
        "Options": [
            "a) When the lower esophagus sphincter does not open",
            "b) When the lower esophagus sphincter is not at all present",
            "c) When the acid from the stomach flows back to the oesophagus",
            "d) When acid in the stomach is not produced in a sufficient amount",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 448,
        "Question": "What are the causes of GERD?",
        "Options": [
            "a) Overproduction of acid",
            "b) Overproduction of acid and over relaxation of lower esophageal sphincter",
            "c) Over relaxation of the lower esophageal sphincter",
            "d) When acid in the stomach is not produced in a sufficient amount",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 449,
        "Question": "How can you understand that a patient has a Barrett’s Esophagus?",
        "Options": [
            "a) When the esophagus starts getting thinner",
            "b) When the oesophagus is no more having the peristaltic movement",
            "c) When upper oesophagus gets lined by red coloured tissue",
            "d) When lower oesophagus gets lined by red coloured tissue",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 450,
        "Question": "Which of the following correctly defines a peptic ulcer?",
        "Options": [
            "a) When the esophagus starts getting thinner",
            "b) A benign lesion of gastric mucosa",
            "c) When upper oesophagus gets lined by red coloured tissue",
            "d) When lower oesophagus gets lined by red coloured tissue",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 451,
        "Question": "Which enzyme of H. pyloric helps it to grow in the acidic medium of the stomach?",
        "Options": [
            "a) Urease",
            "b) Amylase",
            "c) Protease",
            "d) Acid Hydrolases",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 452,
        "Question": "How to diagnose infection by H. pylori?",
        "Options": [
            "a) Histology and culture",
            "b) Antibody test",
            "c) Urease CLO test",
            "d) Antibody test, Urease CLO test, Histology and culture",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 453,
        "Question": "Which cells are also known as chief cells?",
        "Options": [
            "a) Parietal cells",
            "b) Mucous neck cells",
            "c) Peptic cells",
            "d) Superficial epithelial cells",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 454,
        "Question": "How neuronal regulation of gastric acid is done?",
        "Options": [
            "a) Acetylcholine",
            "b) Gastrin",
            "c) Histamine",
            "d) CNS",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 455,
        "Question": "How hormonal regulation of gastric acid is done?",
        "Options": [
            "a) Acetylcholine",
            "b) Gastrin",
            "c) Histamine",
            "d) CNS",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 456,
        "Question": "What is the other name of the food and drug act?",
        "Options": [
            "a) Wiley Act",
            "b) Wily act",
            "c) Will Act",
            "d) Wheel Act",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 457,
        "Question": "What is the full form of the FDA?",
        "Options": [
            "a) Federal Agency",
            "b) Food and Drug Administration",
            "c) Food and Drug Agency",
            "d) Food Drug Alliances",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 458,
        "Question": "For which of the following FDA is not at all responsible?",
        "Options": [
            "a) Foods",
            "b) Radiation-emitting devices",
            "c) Cosmetics",
            "d) Vehicles",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 459,
        "Question": "What do the Pediatric Rule states?",
        "Options": [
            "a) No drug should be tested on children",
            "b) No separate drug for children",
            "c) Include usage of pediatric use of a product",
            "d) Advertise the pediatric usage",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 460,
        "Question": "What is meant by Fast Track provision?",
        "Options": [
            "a) Send medicines fast",
            "b) Common medicines should reach poor people",
            "c) Rapid approval of priority medications",
            "d) Rapid selling of priority medications",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 461,
        "Question": "What is the full form of GMP?",
        "Options": [
            "a) Good manufacturing provisions",
            "b) Good Monitoring prohibitions",
            "c) Good medical practices",
            "d) Good manufacturing practice",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 462,
        "Question": "What is meant by the Good Manufacturing Practice Regulations?",
        "Options": [
            "a) Followed by manufacturing companies",
            "b) Only followed by MNCs",
            "c) Followed in the labs only",
            "d) Followed only for cosmetics",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 463,
        "Question": "What are generic drugs?",
        "Options": [
            "a) Drugs for poor people",
            "b) Patented products can be manufactured by other companies once the patent is lost",
            "c) These drugs do not need FDA approval",
            "d) These drugs don’t have specific guidelines",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 464,
        "Question": "What is the full form of OTC?",
        "Options": [
            "a) Over the counter",
            "b) Once Treated",
            "c) Over the century",
            "d) Over the country",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 465,
        "Question": "What is meant by OTC drugs?",
        "Options": [
            "a) Drugs which are easy to manufacture",
            "b) Drugs which are available without a prescription",
            "c) These drugs do not need FDA approval",
            "d) These drugs don’t have specific guidelines",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 466,
        "Question": "Which of the following devices are included in Class I devices?",
        "Options": [
            "a) Bandages",
            "b) Thermometers",
            "c) Pacemakers",
            "d) Micro ovens",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 467,
        "Question": "Which of the following devices are included in Class II devices?",
        "Options": [
            "a) Bandages",
            "b) Thermometers",
            "c) Pacemakers",
            "d) Micro ovens",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 468,
        "Question": "Which of the following devices are included in Class III devices?",
        "Options": [
            "a) Bandages",
            "b) Thermometers",
            "c) Pacemakers",
            "d) Micro ovens",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 469,
        "Question": "Which of the following is not included in Radiological products?",
        "Options": [
            "a) Stethoscope",
            "b) X rays",
            "c) Microwave ovens",
            "d) Ultrasound",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 470,
        "Question": "Which of the following are not correct on the basis of clinical trials?",
        "Options": [
            "a) Biomedical research studies",
            "b) Behavioral research studies",
            "c) Studies on human subjects",
            "d) Study based only on animals",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 471,
        "Question": "What are the different types of clinical trials according to the U.S. National Institutes of Health?",
        "Options": [
            "a) 6",
            "b) 5",
            "c) 4",
            "d) 3",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 472,
        "Question": "What do you mean by a randomized design?",
        "Options": [
            "a) The subjects do not know which study treatment they receive",
            "b) Patients injected with placebo and active doses",
            "c) Randomly assigning subjects either for placebo or active dose",
            "d) Signed document of the recruited patient for the clinical trial procedures",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 473,
        "Question": "What is meant by a blind subject?",
        "Options": [
            "a) The subjects do not know which study treatment they receive",
            "b) Patients injected with placebo and active doses",
            "c) Fake treatment",
            "d) Signed document of the recruited patient for the clinical trial procedures",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 474,
        "Question": "Which one of the following describes “double dummy”?",
        "Options": [
            "a) The subjects do not know which study treatment they receive",
            "b) Patients injected with placebo and active doses",
            "c) Fake treatment",
            "d) Signed document of the recruited patient for the clinical trial procedures",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 475,
        "Question": "What is placebo?",
        "Options": [
            "a) The subjects do not know which study treatment they receive",
            "b) Patients injected with placebo and active doses",
            "c) Fake treatment",
            "d) Signed document of the recruited patient for the clinical trial procedures",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 476,
        "Question": "What is informed consent in a clinical trial?",
        "Options": [
            "a) The subjects do not know which study treatment they receive",
            "b) Patients injected with placebo and active doses",
            "c) Fake treatment",
            "d) Signed document of the recruited patient for the clinical trial procedures",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 477,
        "Question": "Which one of the following is the last step of a clinical trial process?",
        "Options": [
            "a) Investigator selection",
            "b) Patient recruitment",
            "c) Statistical Analysis",
            "d) Data filed and registration",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 478,
        "Question": "How many people will be selected for phase I trial?",
        "Options": [
            "a) The whole market will be under surveillance",
            "b) 300-3000 people",
            "c) 20-300 people",
            "d) 20-50 people",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 479,
        "Question": "How many people will be selected for phase II trial?",
        "Options": [
            "a) The whole market will be under surveillance",
            "b) 300-3000 people",
            "c) 20-300 people",
            "d) 20-50 people",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 480,
        "Question": "How many people will be selected for phase III trial?",
        "Options": [
            "a) The whole market will be under surveillance",
            "b) 300-3000 people",
            "c) 20-300 people",
            "d) 20-50 people",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 481,
        "Question": "Which one of the following will be checked under phase IV surveillance?",
        "Options": [
            "a) The whole market will be under surveillance",
            "b) 300-3000 people",
            "c) 20-300 people",
            "d) 20-50 people",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 482,
        "Question": "Which of the following country is the most attractive location to perform clinical trials outside the United States?",
        "Options": [
            "a) India",
            "b) China",
            "c) United Kingdom",
            "d) Germany",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 483,
        "Question": "In which phase pharmacodynamics and pharmacokinetics of a drug are studied?",
        "Options": [
            "a) Phase I",
            "b) Phase II",
            "c) Phase III",
            "d) Phase IV",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 484,
        "Question": "What is the full form of SAD?",
        "Options": [
            "a) Secure Assessing dose",
            "b) Single Ascending Dose",
            "c) Sodium Ascending Dose",
            "d) Single Amount Dose",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 485,
        "Question": "What is the full form of MAD?",
        "Options": [
            "a) Multiple Ascending Dose",
            "b) Managing Abnormalities Dose",
            "c) Managing absorption dose",
            "d) Managing Assimilation Dose",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 486,
        "Question": "In which of the phase patients are involved in the trial procedure?",
        "Options": [
            "a) Phase I",
            "b) Phase II",
            "c) Phase III",
            "d) Phase IV",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 487,
        "Question": "Which of the trial phase is for pharmacovigilance?",
        "Options": [
            "a) Phase I",
            "b) Phase II",
            "c) Phase III",
            "d) Phase IV",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 488,
        "Question": "Which of the following will not be an ethical step in the clinical trial procedure?",
        "Options": [
            "a) Clinical trials are not supervised well",
            "b) Full informed consent is taken",
            "c) Permission from the ethics committee",
            "d) Permission before starting the run trial",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 489,
        "Question": "What is GCP?",
        "Options": [
            "a) Good cooperation project",
            "b) Good clinical practice",
            "c) Good cleanliness practice",
            "d) Good Constructor provider",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 490,
        "Question": "Which one of the following will come under Scheduled X drugs?",
        "Options": [
            "a) Narcotics",
            "b) Injectables",
            "c) Serums",
            "d) Vaccines",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 491,
        "Question": "Which one of the following will be under Scheduled H and L drugs?",
        "Options": [
            "a) Narcotics",
            "b) Injectable",
            "c) Serums",
            "d) Vaccines",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 492,
        "Question": "Which one of the following will be under Scheduled C and Cl drugs?",
        "Options": [
            "a) Narcotics",
            "b) Injectable",
            "c) Antibiotics",
            "d) Vaccines",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 493,
        "Question": "Which one of the following will be under Scheduled N drugs?",
        "Options": [
            "a) Narcotics",
            "b) Injectable",
            "c) List of equipment",
            "d) Vaccines",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 494,
        "Question": "What is the full form of IND?",
        "Options": [
            "a) Investigated drug",
            "b) Investigation Application",
            "c) Investigation of New Drug Application",
            "d) Under Investigation",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 495,
        "Question": "What is the full form of NDA?",
        "Options": [
            "a) Investigated drug",
            "b) Investigation Application",
            "c) New Drug Application",
            "d) Under Investigation",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 496,
        "Question": "Which of the following is a law passed by the Indian Government in 1919?",
        "Options": [
            "a) The poisons Act",
            "b) The Poisonous Act",
            "c) The Non-poisonous Act",
            "d) The Non-poisons Act",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 497,
        "Question": "Which of the following is a law passed by the Indian Government in 1930?",
        "Options": [
            "a) The Dangerous Drugs Act",
            "b) The Danger in the drug Act",
            "c) The Non-dangerous drug act",
            "d) The Non-Danger in drug Act",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 498,
        "Question": "Which committee in India has the responsibility of looking after the drug and inquiry about its manufacture procedure?",
        "Options": [
            "a) Drug Enquiring committee",
            "b) Drug Enquiry committee",
            "c) Enquiring the Drug Manufacturing committee",
            "d) Drug Enquiry of the produced Drug committee",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 499,
        "Question": "Which one of the following law was passed in 1931 by the Indian Government?",
        "Options": [
            "a) The poisons Act",
            "b) Drug Enquiring committee",
            "c) The Drugs and Cosmetics Act",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 500,
        "Question": "Which one of the following law was passed in 1985 by the Indian Government?",
        "Options": [
            "a) The poisons Act",
            "b) Drug Enquiring committee",
            "c) The Drugs and Cosmetics Act",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 501,
        "Question": "Which one of the following law was passed in 1945 by the Indian Government?",
        "Options": [
            "a) The poisons Act",
            "b) Drug Enquiring committee",
            "c) The Drugs and Cosmetics Rules",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 502,
        "Question": "Which one of the following law was passed in 1948 by the Indian Government?",
        "Options": [
            "a) The poisons Act",
            "b) Pharmacy Act",
            "c) The Drugs and Cosmetics Rules",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 503,
        "Question": "Which one of the following law was passed in 1954 by the Indian Government?",
        "Options": [
            "a) The poisons Act",
            "b) Drug and Magic Remedies Act",
            "c) The Drugs and Cosmetics Rules",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 504,
        "Question": "Which one of the following law was passed in 1955 by the Indian Government?",
        "Options": [
            "a) Medicinal and Toilet Preparations Act",
            "b) Drug Enquiring committee",
            "c) The Drugs and Cosmetics Rules",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 505,
        "Question": "Which one of the following order was passed in 1955 by the Indian Government?",
        "Options": [
            "a) Drugs order",
            "b) Drug Enquiring committee",
            "c) The Drugs and Cosmetics Rules",
            "d) The Narcotic Drugs and Psychotropic Substances Act",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 506,
        "Question": "If a drug is colored or coated to conceal the damage in it, under which category of drugs shall it come?",
        "Options": [
            "a) Misbranded drugs",
            "b) Spurious drugs",
            "c) Adulterated drugs",
            "d) Impure Drugs",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 507,
        "Question": "If a drug has filthy or decomposed substances in its composition, which type of drug this will be?",
        "Options": [
            "a) Misbranded drugs",
            "b) Spurious drugs",
            "c) Adulterated drugs",
            "d) Impure Drugs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 508,
        "Question": "If the container of the drug has any poisonous and deleterious substances, which type of drug this will be?",
        "Options": [
            "a) Misbranded drugs",
            "b) Spurious drugs",
            "c) Adulterated drugs",
            "d) Impure Drugs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 509,
        "Question": "A drug shall be _____________ if it has imported under a name which belongs to another drug.",
        "Options": [
            "a) Misbranded drug",
            "b) Spurious drug",
            "c) Adulterated drug",
            "d) Impure drug",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 510,
        "Question": "A drug shall be _____________ if it is an imitation or substitute of another drug.",
        "Options": [
            "a) Misbranded drugs",
            "b) Spurious drugs",
            "c) Adulterated drugs",
            "d) Impure Drugs",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 511,
        "Question": "What does the symbol Rx mean?",
        "Options": [
            "a) To take",
            "b) Should date",
            "c) How to take",
            "d) What to take",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 512,
        "Question": "Which one should be written on the top of a prescription?",
        "Options": [
            "a) Patient name",
            "b) Patient address",
            "c) Patient father’s name",
            "d) Patient illness",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 513,
        "Question": "What does the A on a prescription mean?",
        "Options": [
            "a) Adult",
            "b) Under 16 years",
            "c) Under 6 years of age",
            "d) Script for oral contraceptive",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 514,
        "Question": "What does the O on a prescription mean?",
        "Options": [
            "a) Adult",
            "b) Under 16 years",
            "c) Under 6 years of age",
            "d) Script for oral contraceptive",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 515,
        "Question": "What does the J on a prescription mean?",
        "Options": [
            "a) Adult",
            "b) Under 16 years",
            "c) Under 6 years of age",
            "d) Script for oral contraceptive",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 516,
        "Question": "What does the Y on a prescription mean?",
        "Options": [
            "a) Adult",
            "b) Under 16 years",
            "c) Under 6 years of age",
            "d) Script for oral contraceptive",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 517,
        "Question": "The 1st part of the prescription will be having all the below-written information except ____________",
        "Options": [
            "a) How to take the medicines",
            "b) Rx",
            "c) Name of medicine",
            "d) Type of administration",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 518,
        "Question": "Which of the following information should be on the 1st part of the prescription?",
        "Options": [
            "a) Name of medicine",
            "b) How to take the medicine",
            "c) Quantity to be dispensed",
            "d) Signature of the doctor.",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 519,
        "Question": "Which of the following information should be on the 2nd part of the prescription?",
        "Options": [
            "a) Name of medicine",
            "b) How to take the medicine",
            "c) Quantity to be dispensed",
            "d) Signature of the doctor.",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 520,
        "Question": "Which of the following information should be on the 3rd part of the prescription?",
        "Options": [
            "a) Name of medicine",
            "b) How to take the medicine",
            "c) Quantity to be dispensed",
            "d) Signature of the doctor.",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 521,
        "Question": "Which one of the following should be there on a prescription to make it a legal one?",
        "Options": [
            "a) Name of medicine",
            "b) How to take the medicine",
            "c) Quantity to be dispensed",
            "d) Signature of the doctor.",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 522,
        "Question": "What does the abbreviation o.d? means on a prescription?",
        "Options": [
            "a) Name of medicine",
            "b) How to take the medicine",
            "c) Quantity to be dispensed",
            "d) Once daily",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 523,
        "Question": "What do you write on the prescription when the dosage has to be taken in the morning?",
        "Options": [
            "a) Mane",
            "b) Midi",
            "c) Nocte",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 524,
        "Question": "What do you write on the prescription when the dosage has to be taken in the midday?",
        "Options": [
            "a) Mane",
            "b) Midi",
            "c) Nocte",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 525,
        "Question": "What do you write on the prescription when the dosage has to be taken in the night time?",
        "Options": [
            "a) Mane",
            "b) Midi",
            "c) Nocte",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 526,
        "Question": "What do you write on the prescription when the dosage has to be taken before food?",
        "Options": [
            "a) a.c.",
            "b) p.c.",
            "c) p.r.n.",
            "d) p.r.",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 527,
        "Question": "What do you write on the prescription when the dosage has to be taken after food?",
        "Options": [
            "a) a.c.",
            "b) p.c.",
            "c) p.r.n.",
            "d) p.r.",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 528,
        "Question": "What do you write on the prescription when the dosage has to be taken as required?",
        "Options": [
            "a) a.c.",
            "b) p.c.",
            "c) p.r.n.",
            "d) p.r.",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 529,
        "Question": "What do you write on the prescription when the dosage has to be taken through a subcutaneous route?",
        "Options": [
            "a) p.o.",
            "b) s.c.",
            "c) p.r.",
            "d) i.m.",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 530,
        "Question": "What do you write on the prescription when the dosage has to be taken through the oral route?",
        "Options": [
            "a) p.o.",
            "b) s.c.",
            "c) p.r.",
            "d) i.m.",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 531,
        "Question": "What do you write on the prescription when the dosage has to be taken through rectal route?",
        "Options": [
            "a) p.o.",
            "b) s.c.",
            "c) p.r.",
            "d) i.m.",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 532,
        "Question": "The 3rd part of a prescription is prefaced by which of the following?",
        "Options": [
            "a) Mitte",
            "b) Sig",
            "c) Rx",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 533,
        "Question": "The 2nd part of a prescription is prefaced by which of the following?",
        "Options": [
            "a) Mitte",
            "b) Sig",
            "c) Rx",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 534,
        "Question": "The 1st part of a prescription is prefaced by which of the following?",
        "Options": [
            "a) Mitte",
            "b) Sig",
            "c) Rx",
            "d) Eve",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 535,
        "Question": "Which of the following is the definition for diabetes 1?",
        "Options": [
            "a) The immune system destroys beta cells and no more insulin is being produced",
            "b) The body becomes resistant to insulin",
            "c) Insulin is produced but not efficiently used up",
            "d) Receptors for insulin are destroyed",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 536,
        "Question": "Which one of the following will be characteristics of diabetes type 2?",
        "Options": [
            "a) The body becomes resistant to insulin",
            "b) Immune cells destroy beta cells",
            "c) Immune cells destroy kidney",
            "d) Increase of blood sugar",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 537,
        "Question": "What do you understand by the term ‘manifestation’ related to diabetes?",
        "Options": [
            "a) The immune system destroys beta cells and no more insulin is being produced",
            "b) The body becomes resistant to insulin",
            "c) Insulin is produced but not efficiently used up",
            "d) Beta cell destruction",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 538,
        "Question": "What do you mean by polydipsia?",
        "Options": [
            "a) Thirst from dehydration",
            "b) Osmotic diuretic like activity being a hyperglycaemic",
            "c) Hunger",
            "d) Weight loss",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 539,
        "Question": "What do you mean by polyuria?",
        "Options": [
            "a) Thirst from dehydration",
            "b) Osmotic diuretic like activity being a hyperglycaemic",
            "c) Hunger",
            "d) Weight loss",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 540,
        "Question": "What do you mean by polyphagia?",
        "Options": [
            "a) Thirst from dehydration",
            "b) Osmotic diuretic like activity being a hyperglycaemic",
            "c) Hunger",
            "d) Weight loss",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 541,
        "Question": "Which of the following is not a natural phenomenon being a diabetes patient?",
        "Options": [
            "a) Increased urination",
            "b) Thirst from dehydration",
            "c) Less crave for food",
            "d) Weight loss",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 542,
        "Question": "What is gestational diabetes?",
        "Options": [
            "a) The body becomes resistant to insulin",
            "b) Immune cells destroy beta cells",
            "c) Occurs in a pregnant women",
            "d) Increase of blood sugar",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 543,
        "Question": "Which of the following is not a diagnosis of diabetes mellitus?",
        "Options": [
            "a) Casual plasma glucose (non-fasting) is 200 mg/dl",
            "b) Fasting plasma glucose of 126 mg/dl or higher",
            "c) A two-hour plasma glucose level of 200 mg/dl",
            "d) Casual plasma glucose (non-fasting) is 100 mg/dl",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 544,
        "Question": "Which of the following is a symptom for diabetes mellitus?",
        "Options": [
            "a) Fever",
            "b) Bones panning",
            "c) Cold and cough",
            "d) Kussmals respirations",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 545,
        "Question": "Which of the following is a symptom for diabetes mellitus?",
        "Options": [
            "a) Fever",
            "b) Bones panning",
            "c) Fruity breath",
            "d) Increase breathing",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 546,
        "Question": "Which of the following is a drug for diabetes mellitus?",
        "Options": [
            "a) Omeprazole",
            "b) Sulfonylureas",
            "c) Pantoprazole",
            "d) Mannitol",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 547,
        "Question": "Which of the following is a drug for diabetes mellitus?",
        "Options": [
            "a) Omeprazole",
            "b) Acetanilide",
            "c) Pantoprazole",
            "d) Meglitinide",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 548,
        "Question": "Which of the following is a drug for diabetes mellitus?",
        "Options": [
            "a) Omeprazole",
            "b) Acetanilide",
            "c) Biguanides",
            "d) Amlodipine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 549,
        "Question": "Which of the following is a drug for diabetes mellitus?",
        "Options": [
            "a) Alpha-glucoside inhibitors",
            "b) Acetanilide",
            "c) Sucralfate",
            "d) Amlodipine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 550,
        "Question": "Which of the following is a drug for diabetes mellitus?",
        "Options": [
            "a) Thiazolidinedione",
            "b) Acetanilide",
            "c) Thiazide-thiazide like diuretics",
            "d) Amlodipine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 551,
        "Question": "Which of the following sentences can define clearly an insulin analog?",
        "Options": [
            "a) Fully synthetic molecules",
            "b) Modified to act slower or faster",
            "c) Similar to bovine insulin used in other animals",
            "d) Drugs which have a similar structure to the insulin",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 552,
        "Question": "Which of the following is manufactures by Eli Lilly and has been marketed since 1966?",
        "Options": [
            "a) Lispro",
            "b) Insulin Aspart",
            "c) Glulisine",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 553,
        "Question": "Which of the following insulin analogue was approved by the FDA and marketed by Novo Nordisk?",
        "Options": [
            "a) Lispro",
            "b) Insulin Aspart",
            "c) Glulisine",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 554,
        "Question": "Which of the following insulin analogue was available from 206 and marketed by Sanofi-Aventis?",
        "Options": [
            "a) Lispro",
            "b) Insulin Aspart",
            "c) Glulisine",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 555,
        "Question": "Which of the following is a long-acting insulin analogue?",
        "Options": [
            "a) Lispro",
            "b) Insulin aspart",
            "c) Glulisine",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 556,
        "Question": "Which one of the following is marketed by the name Levemir by Novo Nordisk?",
        "Options": [
            "a) Detemir",
            "b) Insulin aspart",
            "c) Glulisine",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 557,
        "Question": "Which of the following is ultra-short-acting insulin analogue?",
        "Options": [
            "a) Detemir",
            "b) Insulin aspart",
            "c) Insulin NPH",
            "d) Glargine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 558,
        "Question": "Which age group is more prone to Multiple sclerosis?",
        "Options": [
            "a) 0-5 years",
            "b) 20-75 years",
            "c) Adults of above 20 years",
            "d) Adults of above 70 years",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 559,
        "Question": "Which of the following is not a key player in Multiple sclerosis?",
        "Options": [
            "a) Axon",
            "b) Myelin",
            "c) Actin",
            "d) T cells",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 560,
        "Question": "APC cells present ______________ antigen to T cells.",
        "Options": [
            "a) Axon",
            "b) Myelin",
            "c) Actin",
            "d) Oligodendrocytes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 561,
        "Question": "What is the problem with the blood-brain barrier of a patient of Multiple Sclerosis?",
        "Options": [
            "a) Springs a leak",
            "b) Allows all T-cells",
            "c) Allows all antigens",
            "d) Becomes rigid even don’t let carbon dioxide pass through.",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 562,
        "Question": "Which of the following is not a symptom for Multiple sclerosis?",
        "Options": [
            "a) Polyphagia",
            "b) Short term memory dysfunction",
            "c) Depression",
            "d) Fatigue",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 563,
        "Question": "Which of the following is not a symptom for Multiple sclerosis?",
        "Options": [
            "a) Constipation",
            "b) Numbness",
            "c) Twitching of eyes",
            "d) Polydipsia",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 564,
        "Question": "How is alpha interferon produced?",
        "Options": [
            "a) Produced by virus-infected leukocytes",
            "b) Produced by virus-infected fibroblasts",
            "c) Produced by activated NK cells",
            "d) Produced by bacterial activated leukocytes",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 565,
        "Question": "How is beta interferon produced?",
        "Options": [
            "a) Produced by virus-infected leukocytes",
            "b) Produced by virus-infected fibroblasts",
            "c) Produced by activated NK cells",
            "d) Produced by bacterial activated leukocytes",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 566,
        "Question": "How are gamma interferon produced?",
        "Options": [
            "a) Produced by virus-infected leukocytes",
            "b) Produced by virus-infected fibroblasts",
            "c) Produced by activated NK cells",
            "d) Produced by bacterial activated leukocytes",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 567,
        "Question": "Which of the following is a drug for Multiple sclerosis?",
        "Options": [
            "a) Avonex and Rebif",
            "b) Sucralfate",
            "c) Pantoprazole",
            "d) Cocaine",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 568,
        "Question": "Which of the following is a drug for Multiple sclerosis?",
        "Options": [
            "a) Betaseron",
            "b) Sucralfate",
            "c) Pantoprazole",
            "d) Cocaine",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 569,
        "Question": "Which of the following is a drug for Multiple sclerosis?",
        "Options": [
            "a) Glatiramer acetate",
            "b) Sucralfate",
            "c) Pantoprazole",
            "d) Cocaine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 570,
        "Question": "Which one of the following is a treatment for Multiple sclerosis?",
        "Options": [
            "a) Decrease depression",
            "b) Prevent damage to BBB",
            "c) Provide glucose so that the patient does not feel fatigued",
            "d) Provide paracetamol to decrease frequent fever",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 571,
        "Question": "What are the characteristics of continuous release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Release as soon as comes in contact to the saliva",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 572,
        "Question": "What is the characteristic of delayed transit and continuous release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Release as soon as comes in contact to the saliva",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 573,
        "Question": "What is the characteristic of delayed release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Release as soon as comes in contact to the saliva",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 574,
        "Question": "What is the characteristic of dissolution controlled release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Very slow dissolution rate",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 575,
        "Question": "What is the characteristic of matrix dissolution-controlled release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Employ waxes to control the rate of dissolution",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 576,
        "Question": "What is the characteristic of encapsulation or coating dissolution-controlled release systems?",
        "Options": [
            "a) Microencapsulation using slowly dissolving materials",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Employ waxes to control the rate of dissolution",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 577,
        "Question": "What are the characteristics of diffusion-controlled release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Diffusion of the dissolved drug",
            "c) Release only at a specific drug",
            "d) Employ waxes to control the rate of dissolution",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 578,
        "Question": "What are the characteristics of Matrix diffusion-controlled release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Drug disperse in an insoluble matrix of rigid hydrophobic materials",
            "c) Release only at a specific drug",
            "d) Employ waxes to control the rate of dissolution",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 579,
        "Question": "What are the characteristics of reservoir devices-controlled release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Drug disperse in the insoluble matrix of rigid hydrophobic materials",
            "c) Hollow systems containing drug surrounded by a polymer membrane",
            "d) Employ waxes to control the rate of dissolution",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 580,
        "Question": "What are the characteristics of ion exchange resin drug complexes?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Drug disperse in an insoluble matrix of rigid hydrophobic materials",
            "c) Hollow systems containing drug surrounded by a polymer membrane",
            "d) Formation of complexes between the drug and anion/cation exchange resins",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 581,
        "Question": "What is the characteristic of pH-independent formulations?",
        "Options": [
            "a) Buffering agents that adjust pH to the desired value",
            "b) Drug disperse in the insoluble matrix of rigid hydrophobic materials",
            "c) Hollow systems containing drug surrounded by a polymer membrane",
            "d) Formation of complexes between the drug and anion/cation exchange resins",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 582,
        "Question": "What are the characteristics of osmotic pressure-controlled systems?",
        "Options": [
            "a) Buffering agents that adjust pH to the desired value",
            "b) Releases the drug at a zero-order kinetics",
            "c) Hollow systems containing drug surrounded by a polymer membrane",
            "d) Formation of complexes between the drug and anion/cation exchange resins",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 583,
        "Question": "What are the characteristics of hydrodynamic pressure controlled systems?",
        "Options": [
            "a) Buffering agents that adjust pH to the desired value",
            "b) Drug disperse in an insoluble matrix of rigid hydrophobic materials",
            "c) Generated by swelling hydrophilic hum",
            "d) Formation of complexes between the drug and anion/cation exchange resins",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 584,
        "Question": "What is the characteristics of altered density systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Release only at a specific drug",
            "d) Use of high or low density pellets",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 585,
        "Question": "What are the characteristics of floating or buoyant capsule systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Granule drug with hydro gel",
            "c) Release only at a specific drug",
            "d) Use of high or low density pellets",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 586,
        "Question": "What is the characteristics of mucoadhesive systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Usage of bio adhesive polymer",
            "d) Use of high or low density pellets",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 587,
        "Question": "Enteric coating are used for which systems?",
        "Options": [
            "a) Intestinal release systems",
            "b) Colonic release systems",
            "c) Size based systems",
            "d) Mucoadhesive systems",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 588,
        "Question": "What are the characteristics of intestinal release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Usage of polymers that dissolves only in the alkaline pH of colon",
            "d) Use of enteric coating",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 589,
        "Question": "What are the characteristics of colonic release systems?",
        "Options": [
            "a) Release the drug along the entire length of GIT",
            "b) Prolonged their residence in the GIT and release",
            "c) Usage of polymers that dissolves only in the alkaline pH of colon",
            "d) Use of enteric coating",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 590,
        "Question": "The duration of action of parental controlled release systems can be extended up to what time?",
        "Options": [
            "a) 1 day",
            "b) 1 week",
            "c) 1 month",
            "d) Day, week, month even a year",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 591,
        "Question": "What is the drawback of parental controlled release systems?",
        "Options": [
            "a) Injecting is a difficulty",
            "b) The drug cannot be easily removed once administered",
            "c) Can get easily precipitated in the injection site",
            "d) Rapid onset but fast excretion",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 592,
        "Question": "Which one of the following should not be a characteristic of the vehicles or polymers which are used for parenteral formulations?",
        "Options": [
            "a) Sterile",
            "b) Consists of pyrogen",
            "c) Nonirritating",
            "d) Biodegradable",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 593,
        "Question": "With aqueous solutions, the drug releases can be controlled. Which of the following is not the right method of controlling?",
        "Options": [
            "a) Increasing the viscosity",
            "b) By forming complexes with macromolecules",
            "c) Reducing the solubility of the parent drug",
            "d) Increasing the pH to make it highly basic",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 594,
        "Question": "Release of water-soluble drugs can be retarded by presenting it as ____________ suspension.",
        "Options": [
            "a) Oil",
            "b) Water",
            "c) Colloidal",
            "d) Freezing",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 595,
        "Question": "Larger particle size leads to ____________ dissolution.",
        "Options": [
            "a) Slower",
            "b) Faster",
            "c) Moderate",
            "d) Normal",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 596,
        "Question": "Which of the following is a characteristic of microspheres?",
        "Options": [
            "a) Free flowing powders",
            "b) Aqueous solutions",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 597,
        "Question": "Which of the following is a characteristic of oil solutions?",
        "Options": [
            "a) Free flowing powders",
            "b) Aqueous solutions",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 598,
        "Question": "Which of the following is a characteristic of aqueous solutions?",
        "Options": [
            "a) Free flowing powders",
            "b) Drug release can be increased by increasing viscosity",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 599,
        "Question": "Which of the following is a characteristic of nanoparticles?",
        "Options": [
            "a) Free flowing powders",
            "b) Aqueous solutions",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Size range 10-100 nm",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 600,
        "Question": "Which of the following is a characteristic of the parental controlled drug release system by liposomes?",
        "Options": [
            "a) Free flowing powders",
            "b) Aqueous solutions",
            "c) Lipid bilayer enclosing the drug",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 601,
        "Question": "Which of the following can be incorporated into a liposome?",
        "Options": [
            "a)  Only drugs and viruses",
            "b) Only Peptides and viruses due to similar characteristics",
            "c) Only viruses",
            "d) Drugs, peptides, viruses, bacteria",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 602,
        "Question": "Which of the following is a characteristic of resealed erythrocytes?",
        "Options": [
            "a) Nonimmunogenic",
            "b) Aqueous solutions",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Size range 10-100 nm",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 603,
        "Question": "Which of the following statement is false for osmotic pumps?",
        "Options": [
            "a) The pump has three concentric circle",
            "b) The innermost is the drug reservoir",
            "c) The drug is contained a permeable polyester bag",
            "d) Outer most rigid rate controlling semipermeable membrane",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 604,
        "Question": "Which of the following statement is true for osmotic pumps?",
        "Options": [
            "a) The tube is made up of stainless steel",
            "b) The innermost is the drug reservoir in a no collapsible bag",
            "c) The drug is contained a permeable polyester bag",
            "d) The outer most cover is soft and easily permeable",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 605,
        "Question": "Which of the following should not be a property of implants?",
        "Options": [
            "a) Environmental stable",
            "b) Biostable",
            "c) Non-toxic",
            "d) Nonremovable",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 606,
        "Question": "Which is the disadvantage for implants?",
        "Options": [
            "a) More effective",
            "b) More prolonged action",
            "c) Significantly small dose",
            "d) Need of microsurgery",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 607,
        "Question": "Which of the following drugs are used in implants?",
        "Options": [
            "a) Pantoprazole",
            "b) Mannitol",
            "c) Amlodipine",
            "d) Morphine antagonist",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 608,
        "Question": "Which of the following is a false statement for vapour pressure pump?",
        "Options": [
            "a) The device consists of two chambers",
            "b) A chamber contains the drug solution",
            "c) Drug solution chamber is separated by rigid walls",
            "d) Vapour chamber contains vaporizable fluids",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 609,
        "Question": "Which of the following is a characteristic of battery powered pumps?",
        "Options": [
            "a) Free flowing powders",
            "b) The system is programmed to release drugs at a controlled rate",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 610,
        "Question": "How are MLV liposomes made?",
        "Options": [
            "a) 2-10 bilayers of lipid",
            "b) Series of concentric bilayers of lipid",
            "c) The single bilayer of lipid",
            "d) 100 bilayer of lipid",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 611,
        "Question": "How are OLV liposomes made?",
        "Options": [
            "a) 2-10 bilayers of lipid",
            "b) Series of concentric bilayers of lipid",
            "c) A single bilayer of lipid",
            "d) 100 bilayer of lipid",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 612,
        "Question": "Which of the following drugs cannot be given as transdermal administration?",
        "Options": [
            "a) Drugs with very short half-lives",
            "b) Drugs with narrow therapeutic indices",
            "c) Easy removal and termination",
            "d) Drugs against peptic ulcer",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 613,
        "Question": "Which of the following characteristics is suitable for transdermal drug?",
        "Options": [
            "a) Large drug dose",
            "b) Large molecular size",
            "c) Drugs with narrow therapeutic indices",
            "d) Drugs which are metabolized in the skin",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 614,
        "Question": "What are the characteristics of the monolithic devices?",
        "Options": [
            "a) The drug has a large therapeutic index",
            "b) Aqueous solutions",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 615,
        "Question": "The rate at which monolithic devices transfer drugs to the patient body is proportional to _______________ of time.",
        "Options": [
            "a) Square of time",
            "b) The square root of time",
            "c) Twice the time",
            "d) Half the time",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 616,
        "Question": "What are the characteristics of the reservoir or membrane devices?",
        "Options": [
            "a) The drug has a large therapeutic index",
            "b) Drug permeation rate is high",
            "c) Control drug release by partitioning the drug from the oil",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 617,
        "Question": "What are the characteristics of the mixed monolithic-reservoir devices?",
        "Options": [
            "a) The drug has a large therapeutic index",
            "b) Drug permeation rate is high",
            "c) The drug-polymer matrix is layered by rate-controlling membrane",
            "d) Administration of emulsions",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 618,
        "Question": "The absorption of the ophthalmic drug does not depend on which of the following?",
        "Options": [
            "a) Physicochemical properties of the permeating molecule",
            "b) Drainage of tears",
            "c) Output of tears",
            "d) Size of the eyeball",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 619,
        "Question": "Which of the following is false in regarding reservoir devices?",
        "Options": [
            "a) These devices are used when the drug permeation rate is rapid",
            "b) The release of the drug is controlled",
            "c) Suitable for low therapeutic indices",
            "d) The drug is contained in a powder form floating on liquid",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 620,
        "Question": "Which of the following is true for monolithic devices?",
        "Options": [
            "a) These devices are used when the drug permeation rate is rapid",
            "b) The release of the drug is controlled",
            "c) Suitable for drugs with large therapeutic indices",
            "d) The drug is contained in a powder form floating on liquid",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 621,
        "Question": "Which of the following is false for monolithic devices?",
        "Options": [
            "a) The drug used for these devices has large therapeutic indices",
            "b) There are three categories of matrix devices",
            "c) 1st type has the drug dissolved in the polymer matrix",
            "d) 2nd type has drug dispersed",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 622,
        "Question": "One of the Main Forces that stabilize covalent structures in proteins is the interaction between the protein and the ____________",
        "Options": [
            "a) Other protein",
            "b) Cells around",
            "c) Solvent",
            "d) Cell debris around",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 623,
        "Question": "What is the disulfide bond?",
        "Options": [
            "a) The ionic bond between S-S",
            "b) Vander Waals interaction between two S atoms",
            "c) The covalent bond between sulfur atoms on two cysteine amino acids",
            "d) The covalent bond between any two sulfur atoms",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 624,
        "Question": "Which bond is weak and allow to be broken and reformed easily?",
        "Options": [
            "a) Disulfide bond",
            "b) H bond",
            "c) Hydrophobic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 625,
        "Question": "Salt bridges are which kind of bonds?",
        "Options": [
            "a) Disulfide bond",
            "b) H bond",
            "c) Hydrophobic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 626,
        "Question": "What is the strength of salt bridges?",
        "Options": [
            "a) 10-15 kcal/mol",
            "b) 20-25 kcal/mol",
            "c) 17-20 kcal/mol",
            "d) 4-7 kcal/mol",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 627,
        "Question": "What is the name of attractions between polar or ionized R groups and water on the surface of the tertiary structure?",
        "Options": [
            "a) Disulfide bond",
            "b) H bond",
            "c) Hydrophilic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 628,
        "Question": "Which of the bonds are between the polar side groups of amino acids?",
        "Options": [
            "a) Disulfide bond",
            "b) Hydrogen bond",
            "c) Hydrophobic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 629,
        "Question": "What is the name of the links between sulfur atoms of two cysteine amino acids?",
        "Options": [
            "a) Disulfide bond",
            "b) H bond",
            "c) Hydrophobic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 630,
        "Question": "What is the approximate strength of the interaction between atoms in a covalent bond?",
        "Options": [
            "a) 500 kJ/mol",
            "b) 150 kJ/mol",
            "c) 100 kJ/mol",
            "d) 250 kJ/mol",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 631,
        "Question": "Which of the following of a protein molecule determines the strength of van der Waals force?",
        "Options": [
            "a) The molecular weight of the protein",
            "b) PI of the protein",
            "c) Number of amino acids present",
            "d) The surface area of the molecule",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 632,
        "Question": " What is the name of the bond which is caused by changes in electron density?",
        "Options": [
            "a) Vander Waals force",
            "b) H bond",
            "c) Hydrophobic interaction",
            "d) Electrostatic bond",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 633,
        "Question": "Which of the following is a characteristic of the secondary structure of a protein?",
        "Options": [
            "a) Amino acid sequence",
            "b) Association of secondary structure",
            "c) Alpha helix and beta sheets",
            "d) Association of polypeptides",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 634,
        "Question": " What is the name of the bond formed between two ions by the sharing of electrons?",
        "Options": [
            "a) Disulfide bond",
            "b) H bond",
            "c) Hydrophobic interaction",
            "d) Covalent bond",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 635,
        "Question": " What is the name of the bond formed between two ions by the transfer of electrons?",
        "Options": [
            "a) Disulfide bond",
            "b) Ionic bond",
            "c) Hydrophobic interaction",
            "d) Covalent bond",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 636,
        "Question": "What is the name of the bond found in metals; holds metal atoms together very strongly?",
        "Options": [
            "a) Disulfide bond",
            "b) Ionic bond",
            "c) Hydrophobic interaction",
            "d) Metallic bond",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 637,
        "Question": "What is the name of the bond formed when electrons are shared equally?",
        "Options": [
            "a) Disulfide bond",
            "b) Nonpolar covalent bond",
            "c) Hydrophobic interaction",
            "d) Metallic bond",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 638,
        "Question": " What is the name of the bond formed when electrons are shared unequally?",
        "Options": [
            "a) Polar covalent bond",
            "b) Nonpolar covalent bond",
            "c) Hydrophobic interaction",
            "d) Metallic bond",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 639,
        "Question": " Which of the following will be a characteristic of homotypic quaternary structure?",
        "Options": [
            "a) Formed by any single peptide chain in a whole protein molecule",
            "b) Arrangement of polypeptide chains",
            "c) Association between identical polypeptides",
            "d) Association between subunits of different structure",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 640,
        "Question": " Intracellular protein tertiary structures mostly held together by ___________",
        "Options": [
            "a) Covalent forces",
            "b) Disulfide bridges",
            "c) Weak forces",
            "d) Ionic bonds",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 641,
        "Question": "Which of the following is a characteristic of a quaternary protein structure?",
        "Options": [
            "a) Formed by any single peptide chain in a whole protein molecule",
            "b) Arrangement of polypeptide chains",
            "c) Arrangement of different folding of the structure",
            "d) Arrangement of the water molecules on the surface",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 642,
        "Question": "What bonds stabilize the extracellular structure of proteins?",
        "Options": [
            "a) Hydrogen bond",
            "b) Disulfide bonds",
            "c) Hydrogen bonds",
            "d) Ionic bonds",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 643,
        "Question": "The only recombinant vaccine that proved highly effective and is currently approved for human use is the vaccine against __________",
        "Options": [
            "a) Rubella virus",
            "b) Poxvirus",
            "c) HPV infection",
            "d) Dengue virus",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 644,
        "Question": "Who developed the Hepatitis B vaccine?",
        "Options": [
            "a) Pasteur",
            "b) Salk",
            "c) Jenner",
            "d) Pablo DT Valenzuela",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 645,
        "Question": "Virus proteins have been expressed in _______________",
        "Options": [
            "a) Bacterial and yeast cells",
            "b) Yeast and mammalian cells",
            "c) Mammalian cells",
            "d) Mammalian, yeast and bacterial cells",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 646,
        "Question": "GARDASIL is an example of ____________",
        "Options": [
            "a) DNA vaccines",
            "b) Recombinant vector vaccines",
            "c) Live vector vaccines",
            "d) RNA vaccines",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 647,
        "Question": "Gardasil protects against which of the HPV types _________",
        "Options": [
            "a) HPV- 6, 11, 16, 18",
            "b) HPV – 5, 6, 16, 18",
            "c) HPV – 1, 2, 5, 11",
            "d) HPV – 1, 2, 16, 18",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 648,
        "Question": "The HPV protein-encoding genes are expressed in _______ vectors to create large amounts of protein.",
        "Options": [
            "a) Bacteria",
            "b) Yeast",
            "c) Virus",
            "d) Protozoa",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 649,
        "Question": "Which polypeptide of cholera enterotoxin is nontoxic but immunogenic?",
        "Options": [
            "a) A1",
            "b) A2",
            "c) B",
            "d) B1",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 650,
        "Question": "What are the disadvantages of recombinant protein or polypeptide vaccines?",
        "Options": [
            "a) High cost and storage",
            "b) Storage and transportation",
            "c) Transportation and cost",
            "d) Cost, transportation, storage",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 651,
        "Question": "Who developed the first vaccine?",
        "Options": [
            "a) Pasteur",
            "b) Salk",
            "c) Jenner",
            "d) Landsteiner",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 652,
        "Question": "What causes smallpox?",
        "Options": [
            "a) Bacteria",
            "b) Virus",
            "c) Fungi",
            "d) Protozoa",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 653,
        "Question": "Vaccines are used in all the forms, except _________",
        "Options": [
            "a) Live-attenuated vaccines",
            "b) Inactivated vaccines",
            "c) Subunit, recombinant, polysaccharide, and conjugate vaccines",
            "d) Attenuated, inactivated, portions of protein, polysaccharides",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 654,
        "Question": "Which vaccine among these is used in its inactivated form?",
        "Options": [
            "a) Influenza",
            "b) Measles",
            "c) Mumps",
            "d) Chickenpox",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 655,
        "Question": "What is the key information required to develop a vaccine?",
        "Options": [
            "a) Molecular pathogenicity of the disease",
            "b) Molecular pathogenicity of the disease-causing organism",
            "c) Unique immunologic response from the host",
            "d) Molecular pathogenicity of the disease and the disease-causing organism",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 656,
        "Question": "Who sets the rules for clinical trials?",
        "Options": [
            "a) NHS- National Health Service",
            "b) NIH- National Institute of Health",
            "c) NDA- New Drug Administration",
            "d) FDA- Food and Drug Administration",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 657,
        "Question": "The BCG vaccine was developed by ___________ and ____________",
        "Options": [
            "a) Albert Calmette and Camille Guérin",
            "b) Marry Currie and Perry Currie",
            "c) Albert Einstein",
            "d) Robert Hook",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 658,
        "Question": "Recombinant engineered vaccines are being extensively explored to eradicate the following factors, except _________",
        "Options": [
            "a) Infectious diseases",
            "b) Cancers",
            "c) Allergies and cancers",
            "d) Mental illness",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 659,
        "Question": "__________ demonstrated a plasmid-induced immune response using mice by inoculating with a plasmid expressing human growth hormone which elicited antibodies instead of faltering growth.",
        "Options": [
            "a) Stephen Johnston",
            "b) Karry Mullis",
            "c) Robert Hook",
            "d) Alexander Fleming",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 660,
        "Question": "Who discovered transformation?",
        "Options": [
            "a) Albert Einstein",
            "b) Robert Hook",
            "c) Fred Griffith",
            "d) Kary Mullis",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 661,
        "Question": "For the process of transformation to take place a bacterial cell must be in a state of ____________",
        "Options": [
            "a) Stability",
            "b) Competence",
            "c) Localization",
            "d) Horizontal",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 662,
        "Question": "Transformation with micro injection is which kind of transformation?",
        "Options": [
            "a) Physical",
            "b) Chemical",
            "c) Electroporation",
            "d) Natural",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 663,
        "Question": "When does S. pneumoniae becomes competent for transformation?",
        "Options": [
            "a) Lag phase",
            "b) Log phase",
            "c) Exponential phase",
            "d) Stationery phase",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 664,
        "Question": "Which of the following things was identified as the transforming principle?",
        "Options": [
            "a) DNA",
            "b) RNA",
            "c) Protein",
            "d) Carbohydrates",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 665,
        "Question": "What should be the minimum weight of DNA that is required for a successful transformation?",
        "Options": [
            "a) 1000 Daltons",
            "b) 100,000 Daltons",
            "c) 300,000 daltons",
            "d) 8 million daltons",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 666,
        "Question": "Which enzyme cleaves the DNA?",
        "Options": [
            "a) Endonucleases",
            "b) Polymerases",
            "c) Ligases",
            "d) Lyases",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 667,
        "Question": "In which of the following organism transformation occurs by the help of membrane vesicles?",
        "Options": [
            "a) S. pneumoniae",
            "b) H. influenzae",
            "c) E. colli",
            "d) M. tuberculosis",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 668,
        "Question": "Artificial transformation in the laboratory is carried out by which of the chemical?",
        "Options": [
            "a) Sodium chloride",
            "b) Magnesium chloride",
            "c) Calcium chloride",
            "d) Potassium chloride",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 669,
        "Question": "Which of the following path of transformation leads to the lysis of the parent cell?",
        "Options": [
            "a) Lysogenic",
            "b) Lytic",
            "c) Lysogenic and lytic pathway",
            "d) Inductive",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 670,
        "Question": "In which phase of growth does the recipient cell take up the donor DNA?",
        "Options": [
            "a) Lag phase",
            "b) Early logarithmic phase",
            "c) Late logarithmic phase",
            "d) Stationary phase",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 671,
        "Question": "Which of the following enzymes acts on the DNA after its entry into the cell?",
        "Options": [
            "a) Ligases",
            "b) Endonucleases",
            "c) Deoxy ribonucleases",
            "d) Exonucleases",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 672,
        "Question": "By whose experiment evidence of the existence of conjugation was established?",
        "Options": [
            "a) Robert Hook",
            "b) Albert Einstein",
            "c) Thomas Bill and Jimmy Bill",
            "d) Joshua Lederberg and Edward Tatum",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 673,
        "Question": "By whose experiment conjugation was proved?",
        "Options": [
            "a) Robert Hook",
            "b) Bernard Davis",
            "c) Thomas Bill and Jimmy Bill",
            "d) Joshua Lederberg and Edward Tatum",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 674,
        "Question": "Which one of the following is true?",
        "Options": [
            "a) The F plasmid encodes the factor which is transferred from one cell to another",
            "b) The factor encoded by the F plasmid is called as Filamentous (F) factor",
            "c)  It is transferred from one cell to another by filament",
            "d) The bacteria must belong to the same species to carry out the conjugation",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 675,
        "Question": "Which of the following made it easier to conclude that physical contact of the cells was necessary for conjugation in Davis experiment?",
        "Options": [
            "a) Filter",
            "b) U – tube",
            "c) Separate medium for different strains of bacterium",
            "d) Distant species of bacterium",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 676,
        "Question": "Who releases the plasmid encoded proteins required for adhering.",
        "Options": [
            "a) Donor cell",
            "b) Recipient cell",
            "c) F+ cell",
            "d) F- cell",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 677,
        "Question": "Conjugation can’t take place between ___________",
        "Options": [
            "a) F- and F+",
            "b) F’ and F-",
            "c) HFR and F-",
            "d) HFR and F+",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 678,
        "Question": "Which one of the following do not have a self-transmissible plasmid?",
        "Options": [
            "a) E. colli",
            "b) Streptococcus",
            "c) Bacillus",
            "d) Enterococcus",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 679,
        "Question": "Which one of the following gets transferred during Hfr conjugation?",
        "Options": [
            "a) F factor",
            "b) F- factor",
            "c) Donor DNA",
            "d) Donor plasmid",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 680,
        "Question": "What is the order of the gene where columns are for different HFR and values denote time?",
        "Options": [
            "a) Azi, Lac, Gal, Ton",
            "b) Lac, Gal, Azi, Ton",
            "c) Gal, Lac, Ton, Azi",
            "d) Tob, Azi, Lac, Gal",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 681,
        "Question": "Conjugation between F+ and F– cell results in _______________",
        "Options": [
            "a)  Two F– cells",
            "b)  F–cell becomes F+",
            "c)  F– cell remains F– cell with a little DNA from F+ cell",
            "d)  Remains the same without any change",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 682,
        "Question": "What is the unidirectional transfer of genetic material from the donor to the recipient is termed?",
        "Options": [
            "a) Conjugation",
            "b) Recombination",
            "c) Transduction",
            "d) Transformation",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 683,
        "Question": "What genetic information (DNA) does an F-plasmid contain?",
        "Options": [
            "a) Chromosomal DNA",
            "b) Non-chromosomal DNA with regulatory genes",
            "c) DNA that codes for proteins to produce pili",
            "d) B and C",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 684,
        "Question": "In conjugation of HFr cell with F– cell the recipient ______________",
        "Options": [
            "a) Stays F–",
            "b) Become F+",
            "c) Become HFr",
            "d) Become F’",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 685,
        "Question": "Why human cells are more preferred for the production of the recombinant protein?",
        "Options": [
            "a) Say in culturing",
            "b) More sterility",
            "c) Can be easily harvested",
            "d) Post-translational modification",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 686,
        "Question": "Which of the following will be a biological method for gene transfer?",
        "Options": [
            "a) Electroporation",
            "b) Microinjection",
            "c) Particle bombardment",
            "d) Baculoviral vector system",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 687,
        "Question": "In which of this method electric field is applied for gene transfer?",
        "Options": [
            "a) Electroporation",
            "b) Microinjection",
            "c) Particle bombardment",
            "d) Sonoporation",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 688,
        "Question": "What should be the voltage/cm for electroporation to work?",
        "Options": [
            "a) 100 – 1000 V/cm",
            "b) 10 – 100 V/cm",
            "c) 10 – 50 V/cm",
            "d) 10000 – 100000 V/cm",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 689,
        "Question": "Which of the following are the characteristics of electroporation?",
        "Options": [
            "a) Suspend the cells in an electroporation cuvette",
            "b) Injecting the DNA into the cell",
            "c) Also known as Biolistics",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 690,
        "Question": "Which of the following are the characteristics of microinjection?",
        "Options": [
            "a) Suspend the cells in an electroporation cuvette",
            "b) Injecting the DNA into the cell",
            "c) Also known as Biolistics",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 691,
        "Question": "Which of the following are the characteristics of particle bombardment?",
        "Options": [
            "a) Suspend the cells in an electroporation cuvette",
            "b) Injecting the DNA into the cell",
            "c) Also known as biolistics",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 692,
        "Question": "Which of the following are the characteristics of sonoporation?",
        "Options": [
            "a) Suspend the cells in an electroporation cuvette",
            "b) Injecting the DNA into the cell",
            "c) Also known as biolistics",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 693,
        "Question": "Which of the following are the characteristics of laser-induced transfection?",
        "Options": [
            "a) Fin focus of laser light is used",
            "b) Injecting the DNA into the cell",
            "c) Also known as biolistic",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 694,
        "Question": "Which of the following are the characteristics of bead transfection?",
        "Options": [
            "a) Suspend the cells in an electroporation cuvette",
            "b) Physically breaking the cells",
            "c) Also known as Biolistic",
            "d) Usage of ultrasound",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 695,
        "Question": "Which of the following do not incorporate in the genome and replicates in the cytoplasm?",
        "Options": [
            "a) Poxvirus",
            "b) Baculovirus",
            "c) Adenovirus",
            "d) Retrovirus",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 696,
        "Question": "Bacterial gene delivery is known as _____________",
        "Options": [
            "a) Transduction",
            "b) Bactofection",
            "c) Infection",
            "d) Conjugation",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 697,
        "Question": "Bead transfection is physically producing breaks in the cellular membrane using _____________",
        "Options": [
            "a) Beads",
            "b) Electric current",
            "c) Ultrasound",
            "d) Laser light",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 698,
        "Question": "What had helped the study of the structure of antibodies in 1970?",
        "Options": [
            "a) APC",
            "b) Red blood cells",
            "c) Killer cells",
            "d) Cancer myeloma B-cell",
            ""
        ],
        "Answer": "Answer:  d"
    },
    {
        "id": 699,
        "Question": "Who invented the process of producing monoclonal antibodies in 1975?",
        "Options": [
            "a) Albert Einstein",
            "b) Watson and Creek",
            "c) Georges Köhler and César Milstein",
            "d) Robert Hook",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 700,
        "Question": "What has become an important tool in biochemistry, molecular biology, and medicine?",
        "Options": [
            "a) DNA structure",
            "b) Genome sequencing",
            "c) MCA",
            "d) PCR",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 701,
        "Question": "For how many weeks should you titer the Flow cytometry solution to get pure antigen?",
        "Options": [
            "a) 1 month",
            "b) 3 weeks",
            "c) 7 weeks",
            "d) 2 weeks",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 702,
        "Question": "What do you add to Myeloma cells to receive HGPRT- myeloma cells?",
        "Options": [
            "a) 8 – Azaguanine",
            "b) Azaguanine",
            "c) Nitrogen flush",
            "d) Carbon dioxide flush",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 703,
        "Question": "What do we get when we fuse Spleen cells and Myeloma cells?",
        "Options": [
            "a) Hybridoma cells",
            "b) Red blood cells",
            "c) Killer cells",
            "d) Cancer myeloma B-cell",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 704,
        "Question": "What is the method to harvest monoclonal antibodies from the positive clones?",
        "Options": [
            "a) Subculture in the new medium",
            "b) Bioreactors",
            "c) One a single media plate",
            "d) Tissue culture method",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 705,
        "Question": "The cell fusion happens between spleen cells and _____________",
        "Options": [
            "a) Red blood cells",
            "b) Cancer cell",
            "c) Myeloma cells",
            "d) Leukocytes",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 706,
        "Question": "For which discovery did Georges Köhler and César Milstein share the noble prize in 1984?",
        "Options": [
            "a) Inventing genome sequencing",
            "b) Discovery the structure of DNA",
            "c) Discovery of B-cell cancer myeloma",
            "d) Discovery of the process of producing monoclonal antibodies",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 707,
        "Question": "What is the clinical application of monoclonal antibodies?",
        "Options": [
            "a) Biosensors",
            "b) Transplant rejection",
            "c) Infectious disease",
            "d) Purification of drugs",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 708,
        "Question": "MAbs was modified for delivery of a toxin, radioisotope and __________",
        "Options": [
            "a) Enzymes",
            "b) Hormones",
            "c) Drugs",
            "d) Cytokine",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 709,
        "Question": "Bispecific antibodies can bind with their Fab regions both to target antigen and to _____________",
        "Options": [
            "a) Other antibodies",
            "b) An effector cell",
            "c) Proteins around",
            "d) Prostaglandins",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 710,
        "Question": "Six types of bioreactors are, Continuous Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fluidized Bed Bioreactors, Packed Bed Bioreactors and ____________",
        "Options": [
            "a) Hollow fibre reactor",
            "b) General purpose reactor",
            "c) Assembly reactor",
            "d) Photo bioreactor",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 711,
        "Question": "How much fraction is the diameter of impeller than the diameter of the vessel in a stirred tank bioreactor?",
        "Options": [
            "a) 1/5",
            "b) 1/3",
            "c) 1/2",
            "d) 1/1",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 712,
        "Question": "Sparger in stirred tank bioreactor helps in ________________",
        "Options": [
            "a) Proper gas distribution",
            "b) Proper mixing of medium",
            "c) Measuring temperature of medium",
            "d) Better sterility",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 713,
        "Question": "Impellers in stirred tank bioreactors helps in ________________",
        "Options": [
            "a) Breaking down large bubbles into smaller ones",
            "b) Mixing of medium contents",
            "c) Homogenisation",
            "d) Homogenisation, mixing, breaking bubbles",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 714,
        "Question": " What is the aspect ratio of bubble column bioreactors?",
        "Options": [
            "a) 1-3",
            "b) 3-5",
            "c) 4-6",
            "d) 8-10",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 715,
        "Question": "Which of the following is a characteristic for airlift bioreactors?",
        "Options": [
            "a) More efficient than bubble column reactors",
            "b) Less efficient than bubble column reactors",
            "c) Equally efficient as bubble column reactors",
            "d) Not at all efficient",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 716,
        "Question": "What is the most important thing one should remember while working with fluidized bed reactor?",
        "Options": [
            "a) Gas dispersion",
            "b) Medium pH",
            "c) Temperature",
            "d) Weight of solid particles",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 717,
        "Question": "Why packed bed bioreactors are good?",
        "Options": [
            "a) Does not allow accumulation of products",
            "b) Allow ease in pH controlling",
            "c) Allow proper gas distribution",
            "d) Less concentration of enzymes or cells required because of immobilisation",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 718,
        "Question": "Which microbes are used in photobioreactors?",
        "Options": [
            "a) Fungi",
            "b) Bacteria",
            "c) Microalgae",
            "d) Cyanobateria",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 719,
        "Question": "What is the value of μmf / μf for fluidized bed fermenter?",
        "Options": [
            "a) 0.02 – 0.5",
            "b) 0.05-0.08",
            "c) 1.0-1.2",
            "d) 0.0-0.02",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 720,
        "Question": "What may cause foaming in a bioreactor?",
        "Options": [
            "a) A decrease in agitation",
            "b) The formation of large stable bubbles",
            "c) The formation of small unstable bubbles",
            "d) The breaking of large unstable bubbles",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 721,
        "Question": "How does impeller speed affect bubble size?",
        "Options": [
            "a) As impeller speed increases, the bubble size increases",
            "b) As impeller speed increases, bubble size stays consistent",
            "c) As impeller speed increases, bubble size becomes inconsistent",
            "d) As impeller speed increases, the bubble size decreases",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 722,
        "Question": "In a chemostat operating under steady state, a bacterial culture can be grown at dilution rate higher than the maximum growth rate by _________",
        "Options": [
            "a) Partial cell recycling",
            "b) Using sub optimal temperature",
            "c) pH cycling",
            "d) Substrate feed rate cycling",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 723,
        "Question": "What are antibiotics?",
        "Options": [
            "a) Nutrient supplements",
            "b) Anti-cancer drugs",
            "c) Anti-microbial drugs",
            "d) Anti-ulcer drugs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 724,
        "Question": "Who discovered the first antibiotic?",
        "Options": [
            "a) Alexander Fleming",
            "b) Louis Pasteur",
            "c) Francis Crick",
            "d) Kary Mullis",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 725,
        "Question": "How many antibiotics have still been isolated?",
        "Options": [
            "a) 5000",
            "b) 2000",
            "c) 7000",
            "d) 3000",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 726,
        "Question": "Antibiotics are mainly produced by _________",
        "Options": [
            "a) Bacteria",
            "b) Algae",
            "c) Fungi",
            "d) Fungi and bacteria",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 727,
        "Question": "How inoculum is prepared in the production of antibiotics?",
        "Options": [
            "a) On solid media",
            "b) On liquid media",
            "c) First on solid media than on liquid media",
            "d) On suspension",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 728,
        "Question": "Penicillin is active against ____________",
        "Options": [
            "a) Gram +ve bacteria",
            "b) Gram-ve bacteria",
            "c) All virus",
            "d) All bacteria",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 729,
        "Question": "What is the precursor of penicillin?",
        "Options": [
            "a) Benzylpenicillin",
            "b) Isopenicillin N",
            "c) phenylacetic acid",
            "d) L-α aminoadipic acid",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 730,
        "Question": "pH required for the production of penicillin will be ______________",
        "Options": [
            "a) 8.0",
            "b) 7.5",
            "c) 6.5",
            "d) 5.0",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 731,
        "Question": "The doubling time of Penicillium notatum is ___________",
        "Options": [
            "a) 6 hrs",
            "b) 5 hrs",
            "c) 4 hrs",
            "d) 3 hrs",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 732,
        "Question": "How is penicillin stored?",
        "Options": [
            "a) Filtration",
            "b) Crystallization",
            "c) Distillation",
            "d) Sublimation",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 733,
        "Question": "Streptomycin is _____ antibiotic.",
        "Options": [
            "a) Narrow spectrum",
            "b) Broad spectrum",
            "c) Narrow and broad spectrum",
            "d) Medium spectrum",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 734,
        "Question": "How is streptomycin recovered?",
        "Options": [
            "a) Paper chromatography",
            "b) Hydrophobic chromatography",
            "c) Size exclusion chromatography",
            "d) Ion exchange chromatography",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 735,
        "Question": "pH range required for streptomycin production is __________",
        "Options": [
            "a) 7-8",
            "b) 5-8",
            "c) 4-5",
            "d) 9-10",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 736,
        "Question": "Why are Enzymes active only over small range of pH?",
        "Options": [
            "a) Its enzymes property",
            "b) Due to non-active site functional group charges",
            "c) Due to the active site functional group charges",
            "d) It prevents from structure destruction",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 737,
        "Question": "What is the suitable form of ionic group of enzymes?",
        "Options": [
            "a) Acidic or basic",
            "b) Acidic",
            "c) Basic",
            "d) neutral",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 738,
        "Question": "If the substrate contains ionic groups, what happens to the pH of the medium?",
        "Options": [
            "a) The pH of medium increases",
            "b) The pH of medium decreases",
            "c) The pH of medium remains same",
            "d) The pH of medium affects the affinity of substrate to enzyme",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 739,
        "Question": "What is the term given to restriction of enzyme mobility in a fixed space?",
        "Options": [
            "a) Enzyme deactivation",
            "b) Enzyme saturation",
            "c) Enzyme activation",
            "d) Enzyme immobilization",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 740,
        "Question": "What is the product obtained from glucose isomerase?",
        "Options": [
            "a) Amino acids",
            "b) High fructose corn syrup",
            "c) Penicillin",
            "d) Acrylamide",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 741,
        "Question": "Which enzyme gives Acrylamide as a product?",
        "Options": [
            "a) Nitrile Hydratase",
            "b) Glucose isomerase",
            "c) Penicillin acylase",
            "d) Beta-Galactosidase",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 742,
        "Question": "Why is the enzyme solution mixed with a polymeric fluid?",
        "Options": [
            "a) To make it more potent",
            "b) Faster reaction",
            "c) More active sites on the surface",
            "d) Solidifies into various forms",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 743,
        "Question": "Which one is a matrix for entrapment?",
        "Options": [
            "a) Cellulose",
            "b) Polysulfone",
            "c) Nylon",
            "d) Collagen",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 744,
        "Question": "Membrane materials include: Nylon, cellulose, polysulfone and _______________",
        "Options": [
            "a) Collagen",
            "b) Polyacrylamide",
            "c) Agar",
            "d) Polyacrylate",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 745,
        "Question": "Which membrane configuration is used for separating enzyme from substrate and product solution?",
        "Options": [
            "a) Packed column reactor",
            "b) Hollow fibre configuration",
            "c) Fluidized bed reactor",
            "d) Stirred tank reactor",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 746,
        "Question": "What is the name of the method used to cross link enzyme molecules with each other using agents such as glutaraldehyde?",
        "Options": [
            "a) Cross linking",
            "b) Polyacrylamide",
            "c) Agar",
            "d) Polyacrylate",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 747,
        "Question": "What term is given to “enzymes physically confined or localized in a certain defined region of space with retention of their catalytic activities, and which can be used repeatedly and continuous?",
        "Options": [
            "a) Localized enzymes",
            "b) Localisation of enzymes",
            "c) Immobilized enzymes",
            "d) Catalysed enzymes",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 748,
        "Question": "Who reported the first industrial use of immobilized enzymes in 1967?",
        "Options": [
            "a) Robert Hook",
            "b) Chibata and co-workers",
            "c) James Watson",
            "d) Kary Mullis",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 749,
        "Question": "The most common procedures of irreversible enzyme immobilization are covalent coupling, entrapment or micro-encapsulation and ____________",
        "Options": [
            "a) Hydrophilic linkage",
            "b) Di-sulphide bonding",
            "c) Covalent bonding",
            "d) Cross-linking",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 750,
        "Question": "What is the method name that is based on the occlusion of an enzyme within a polymeric network that allows the substrate and products to pass through but retains the enzyme?",
        "Options": [
            "a) The entrapment method",
            "b) Covalent coupling",
            "c) Microencapsulation",
            "d) Hollow fibre",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 751,
        "Question": "In physical adsorption the enzymes are attached to the matrix through hydrogen bonding, van der Waals forces, or hydrophobic interactions; whereas in ionic bonding, the enzymes are bound through?",
        "Options": [
            "a) Hydrophilic linkage",
            "b) Di-sulphide bonding",
            "c) Salt linkages",
            "d) Cross-linking",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 752,
        "Question": "Which of the physical property of the matrices particularly determine the surface area and binding capacity?",
        "Options": [
            "a) Swelling behaviour",
            "b) Mechanical strength",
            "c) Compression behaviour",
            "d) Pore parameters",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 753,
        "Question": "Which of the following are natural mineral polymers?",
        "Options": [
            "a) Cellulose",
            "b) Dextran",
            "c) Agar",
            "d) Silica",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 754,
        "Question": "What is the name of the method used to attach enzymes to stationary solids by weak physical forces?",
        "Options": [
            "a) Absorption",
            "b) Cross linking",
            "c) Adsorption",
            "d) Capillary action",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 755,
        "Question": "Which of the following is false for a biosensor?",
        "Options": [
            "a) Self-contained integrated device",
            "b) Capable of providing specific information",
            "c) Uses a biological recognition",
            "d) Don’t connect to a transduction element",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 756,
        "Question": "Who is the father of Biosensor?",
        "Options": [
            "a) Robert hook",
            "b) Thomas Alva Edison",
            "c) Professor Leland C Clark Jnr",
            "d) Einstein",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 757,
        "Question": "Which of the statement for a biosensor is false?",
        "Options": [
            "a) The linearity of the sensor should be ‘high’",
            "b) Value of the electrode response per substrate concentration should be low",
            "c) Chemicals Interference must be minimized for obtaining the correct result",
            "d) Response time should be low",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 758,
        "Question": "Which of the following defines an analyte?",
        "Options": [
            "a) Any molecule may be protein, toxin, antigen, etc",
            "b) The concentration of the molecule",
            "c) The component which should not be detected",
            "d) The component which gives background noise",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 759,
        "Question": "In a pregnancy kit, which molecule does the kit actually test for?",
        "Options": [
            "a) Baby’s urine test",
            "b) Blood test",
            "c) HCG test",
            "d) Amniotic fluid test",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 760,
        "Question": "Which of the following is a characteristic of calorimetric biosensors?",
        "Options": [
            "a) Detects the change in light adsorption",
            "b) Detects the photon out for luminescent",
            "c) Detects the movement of electrons between electrodes",
            "d) Detects the angle at which electrons are emitted",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 761,
        "Question": "Which of the following is a characteristic of photometric biosensors?",
        "Options": [
            "a) Detects the change in light adsorption",
            "b) Detects the photon out for luminescent",
            "c) Detects the movement of electrons between electrodes",
            "d) Detects the angle at which electrons are emitted",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 762,
        "Question": "Which of the following is a characteristic of electrochemical biosensors?",
        "Options": [
            "a) Detects the change in light adsorption",
            "b) Detects the photon out for luminescent",
            "c) Detects the movement of electrons between electrodes",
            "d) Detects the angle at which electrons are emitted",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 763,
        "Question": "Which of the following is a characteristic of piezoelectric biosensors?",
        "Options": [
            "a) Detects the change in light adsorption",
            "b) Detects the photon out for luminescent",
            "c) Detects the movement of electrons between electrodes",
            "d) Detects the angle at which electrons are emitted",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 764,
        "Question": "Which of the following is a characteristic of DNA biosensors?",
        "Options": [
            "a) Detects the change in light adsorption",
            "b) Detects the photon out for luminescent",
            "c) Detects the movement of electrons between electrodes",
            "d) Formation of DNA recognition layer",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 765,
        "Question": "Which is not a type of intellectual property?",
        "Options": [
            "a) Trade secrets",
            "b) Trademarks",
            "c) Home loans",
            "d) Copyrights",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 766,
        "Question": "In which article is intellectual property rights outlined?",
        "Options": [
            "a) Article 15",
            "b) Article 27",
            "c) Article 13",
            "d) Article 20",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 767,
        "Question": " How long does intellectual property last? (after the death of the author)",
        "Options": [
            "a) 10 yrs",
            "b) 30 yrs",
            "c) 60 yrs",
            "d) 70 yrs",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 768,
        "Question": "Which of the following can you copyright?",
        "Options": [
            "a) Literary work",
            "b) Ideas",
            "c) Choreographic work",
            "d) Fashion",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 769,
        "Question": "Which of the following identifies as a trademark?",
        "Options": [
            "a) Name, symbol",
            "b) Symbol, logo",
            "c) Logo, name",
            "d) Name, symbol, logo",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 770,
        "Question": "Which is a negative aspect of the trademark?",
        "Options": [
            "a) Consumers are able to identify products quickly",
            "b) Monopoly power",
            "c) Brand extension",
            "d) Distinguishes duplicates",
            ""
        ],
        "Answer": "Answer: c"
    },
    {
        "id": 771,
        "Question": "What is the subject matter of a patent?",
        "Options": [
            "a) Art",
            "b) Invention",
            "c) Goods",
            "d) Ideas",
            ""
        ],
        "Answer": "Answer: b"
    },
    {
        "id": 772,
        "Question": "Where is the headquarters of WIPO?",
        "Options": [
            "a) Geneva, Switzerland",
            "b) London, UK",
            "c) Delhi, India",
            "d) Stockholm, Sweden",
            ""
        ],
        "Answer": "Answer: a"
    },
    {
        "id": 773,
        "Question": "Which of the following is (are) included in Geographical indications of Good?",
        "Options": [
            "a) Handicraft",
            "b) Foodstuff and handicrafts",
            "c) Manufactured and foodstuff",
            "d) Handicraft, foodstuff, and manufactures",
            ""
        ],
        "Answer": "Answer: d"
    },
    {
        "id": 774,
        "Question": "Design does not include _________",
        "Options": [
            "a) Features of shape",
            "b) Composition of lines or colours",
            "c) Mode or principle of construction",
            "d) Principle of colours",
            ""
        ],
        "Answer": "Answer: c"
    }
]